Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionbenzodiazepine receptor binding

RIMBP3 RIMBP3C RIMBP3B

1.99e-0651183GO:0030156
GeneOntologyMolecularFunctionprotein-macromolecule adaptor activity

DAB2IP ANK3 MAP1A TCOF1 BCLAF1 PHF12 DAB2 XK SORBS1 GAB2 LPIN1 YEATS2 KMT2C STX18 TLE3 TLE4 POLD3 DNAJB2 HDGFL2 WWC1

1.43e-05116011820GO:0030674
GeneOntologyMolecularFunctionmodification-dependent protein binding

RAD18 ANK3 YEATS2 KMT2A MLLT1 DNAJB2 HDGFL2 CBX2

3.10e-052061188GO:0140030
GeneOntologyMolecularFunctionmolecular adaptor activity

DAB2IP ANK3 MAP1A TCOF1 BCLAF1 PHF12 DAB2 XK SORBS1 GAB2 LPIN1 YEATS2 KMT2C STX18 TLE3 TLE4 POLD3 DNAJB2 HDGFL2 WWC1

1.28e-04135611820GO:0060090
GeneOntologyMolecularFunctioncadherin binding

DAB2IP ANK3 SH3GL1 EPN2 ARHGAP1 BAIAP2L1 WASF2 TMPO PHLDB2

1.86e-043391189GO:0045296
GeneOntologyMolecularFunctionSH3 domain binding

DAB2IP SH3GL1 ARHGAP1 SYNJ2 ARHGAP31 WASF2

2.07e-041431186GO:0017124
GeneOntologyCellularComponentaxon initial segment

ANK3 MAP1A SCN8A NAV1

2.05e-05291184GO:0043194
GeneOntologyCellularComponentcell leading edge

CDC42BPA PODXL MCC ARHGAP1 PTPN13 SYNJ2 ARHGAP31 WASF2 SSX2IP FGD6 WWC1 PHLDB2

2.64e-0550011812GO:0031252
GeneOntologyCellularComponentmethyltransferase complex

RBM15 PHF20 KMT2C KMT2A BOD1L1 UTY

3.41e-051081186GO:0034708
GeneOntologyCellularComponenthistone methyltransferase complex

PHF20 KMT2C KMT2A BOD1L1 UTY

6.63e-05751185GO:0035097
GeneOntologyCellularComponentmain axon

ANK3 MAP1A MAP1B SCN8A NAV1

1.50e-04891185GO:0044304
GeneOntologyCellularComponentmicrotubule associated complex

MAP1A KIF1A MAP1B MAP4 KATNAL1 HAUS8

3.08e-041611186GO:0005875
GeneOntologyCellularComponentlamellipodium

CDC42BPA PODXL MCC PTPN13 ARHGAP31 WASF2 FGD6

3.34e-042301187GO:0030027
GeneOntologyCellularComponentmanchette

RIMBP3 RIMBP3C RIMBP3B

5.18e-04281183GO:0002177
GeneOntologyCellularComponentruffle

PODXL ARHGAP1 SYNJ2 WASF2 FGD6 WWC1

1.12e-032061186GO:0001726
GeneOntologyCellularComponentanchoring junction

FLT1 CDC42BPA ANK3 PODXL SH3GL1 DAB2 SORBS1 SPECC1L SLC4A2 BAIAP2L1 ARHGAP31 WASF2 SSX2IP PHLDB2

1.21e-0397611814GO:0070161
DomainAT_hook

PHF20 KMT2C KMT2A BOD1L1 CBX2

6.13e-07271165SM00384
DomainAT_hook_DNA-bd_motif

PHF20 KMT2C KMT2A BOD1L1 CBX2

6.13e-07271165IPR017956
DomainZnf_PHD-finger

PHF20 PHF12 PHRF1 KMT2C BRPF1 KMT2A

9.68e-06791166IPR019787
DomainPHD

PHF20 PHF12 PHRF1 KMT2C BRPF1 KMT2A

1.92e-05891166SM00249
DomainZnf_PHD

PHF20 PHF12 PHRF1 KMT2C BRPF1 KMT2A

2.19e-05911166IPR001965
DomainZF_PHD_2

PHF20 PHF12 PHRF1 KMT2C BRPF1 KMT2A

2.79e-05951166PS50016
DomainZF_PHD_1

PHF20 PHF12 PHRF1 KMT2C BRPF1 KMT2A

2.96e-05961166PS01359
DomainZnf_FYVE_PHD

PHF20 PHF12 PHRF1 KMT2C BRPF1 KMT2A FGD6

3.70e-051471167IPR011011
DomainPHD

PHF20 PHF12 PHRF1 KMT2C KMT2A

1.03e-04751165PF00628
DomainMAP1

MAP1A MAP1B

1.14e-0431162IPR026074
DomainSH3_9

SORBS1 RIMBP3 BAIAP2L1 RIMBP3C RIMBP3B

1.25e-04781165PF14604
DomainSH3_2

SORBS1 RIMBP3 BAIAP2L1 RIMBP3C RIMBP3B

1.98e-04861165PF07653
DomainSH3_2

SORBS1 RIMBP3 BAIAP2L1 RIMBP3C RIMBP3B

1.98e-04861165IPR011511
DomainYEATS

YEATS2 MLLT1

2.28e-0441162PS51037
DomainYEATS

YEATS2 MLLT1

2.28e-0441162IPR005033
DomainYEATS

YEATS2 MLLT1

2.28e-0441162PF03366
DomainUIM

USP28 EPN2 DNAJB2

2.86e-04211163SM00726
DomainPH_dom-like

DAB2IP CDC42BPA KIF1A DAB2 GAB2 PLEKHG1 PTPN13 FRMPD3 FGD6 PHLDB2

3.25e-0442611610IPR011993
DomainEPHD

KMT2C BRPF1 KMT2A

3.30e-04221163PS51805
DomainFYrich_C

KMT2C KMT2A

3.78e-0451162IPR003889
DomainFYrich_N

KMT2C KMT2A

3.78e-0451162IPR003888
DomainFYRC

KMT2C KMT2A

3.78e-0451162SM00542
DomainFYRN

KMT2C KMT2A

3.78e-0451162SM00541
DomainGroucho_enhance

TLE3 TLE4

3.78e-0451162IPR009146
DomainTLE_N

TLE3 TLE4

3.78e-0451162PF03920
DomainGroucho/TLE_N

TLE3 TLE4

3.78e-0451162IPR005617
DomainFYRN

KMT2C KMT2A

3.78e-0451162PF05964
DomainFYRC

KMT2C KMT2A

3.78e-0451162PF05965
DomainFYRC

KMT2C KMT2A

3.78e-0451162PS51543
DomainFYRN

KMT2C KMT2A

3.78e-0451162PS51542
DomainUIM

USP28 EPN2 DNAJB2

4.30e-04241163PS50330
DomainUIM_dom

USP28 EPN2 DNAJB2

4.86e-04251163IPR003903
Domain-

DAB2IP CDC42BPA KIF1A DAB2 GAB2 PLEKHG1 PTPN13 FGD6 PHLDB2

7.49e-0439111692.30.29.30
DomainHMGI/Y_DNA-bd_CS

PHF20 KMT2C CBX2

9.24e-04311163IPR000637
DomainFHA_DOMAIN

KIF1A PHF12 MKI67

9.24e-04311163PS50006
Domain-

KIF1A PHF12 MKI67

1.44e-033611632.60.200.20
DomainFHA_dom

KIF1A PHF12 MKI67

1.44e-03361163IPR000253
DomainPH

DAB2IP CDC42BPA KIF1A GAB2 PLEKHG1 FGD6 PHLDB2

1.76e-032781167SM00233
DomainPH_DOMAIN

DAB2IP CDC42BPA KIF1A GAB2 PLEKHG1 FGD6 PHLDB2

1.80e-032791167PS50003
DomainPH_domain

DAB2IP CDC42BPA KIF1A GAB2 PLEKHG1 FGD6 PHLDB2

1.83e-032801167IPR001849
DomainSET

PRDM2 KMT2C KMT2A

2.10e-03411163PF00856
DomainBROMODOMAIN_2

BRPF1 KMT2A BRWD1

2.10e-03411163PS50014
DomainBromodomain

BRPF1 KMT2A BRWD1

2.25e-03421163IPR001487
DomainBROMO

BRPF1 KMT2A BRWD1

2.25e-03421163SM00297
Domain-

BRPF1 KMT2A BRWD1

2.25e-034211631.20.920.10
DomainSH3

SH3GL1 SORBS1 RIMBP3 BAIAP2L1 RIMBP3C RIMBP3B

2.31e-032161166SM00326
DomainSH3

SH3GL1 SORBS1 RIMBP3 BAIAP2L1 RIMBP3C RIMBP3B

2.31e-032161166PS50002
DomainSH3_domain

SH3GL1 SORBS1 RIMBP3 BAIAP2L1 RIMBP3C RIMBP3B

2.53e-032201166IPR001452
Domain-

TCEA3 HDGFL2

2.85e-031311621.20.930.10
DomainSET

PRDM2 KMT2C KMT2A

2.92e-03461163SM00317
DomainPH

CDC42BPA KIF1A GAB2 PLEKHG1 FGD6 PHLDB2

3.08e-032291166PF00169
DomainRas_G-nucl-exch_fac_CS

RALGDS RGL1

3.31e-03141162IPR019804
DomainTFIIS_N

TCEA3 HDGFL2

3.31e-03141162IPR017923
DomainWD40_repeat_CS

WDR11 TLE3 TLE4 KCTD3 BRWD1

3.60e-031641165IPR019775
DomainSET_dom

PRDM2 KMT2C KMT2A

3.70e-03501163IPR001214
DomainSET

PRDM2 KMT2C KMT2A

3.70e-03501163PS50280
DomainSMAD_FHA_domain

KIF1A PHF12 MKI67

4.13e-03521163IPR008984
DomainPost-SET_dom

KMT2C KMT2A

4.34e-03161162IPR003616
DomainPostSET

KMT2C KMT2A

4.34e-03161162SM00508
DomainAT_hook

KMT2C KMT2A

4.34e-03161162PF02178
DomainPOST_SET

KMT2C KMT2A

4.34e-03161162PS50868
DomainUIM

EPN2 DNAJB2

5.48e-03181162PF02809
DomainUbiquitin-rel_dom

RAF1 RALGDS RGL1 PTPN13 FRMPD3

5.84e-031841165IPR029071
PathwayREACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES

PHF20 YEATS2 KMT2C KMT2A BOD1L1

5.35e-0642865M48018
PathwayREACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES

PHF20 YEATS2 KMT2A BOD1L1

8.14e-0538864MM17073
PathwayREACTOME_RAC1_GTPASE_CYCLE

CDC42BPA PLEKHG1 ARHGAP1 BAIAP2L1 ARHGAP31 WASF2 TMPO

1.30e-04184867M41809
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

RAF1 RBM15 CDC42BPA MAP1B MAP4 MARK3 SH3GL1 SORBS1 DENND4C GAB2 EPN2 CEP350 IVNS1ABP USP31 PLEKHG1 HAUS8 PTPN13 BAIAP2L1 ATXN1 SYNJ2 SIPA1L1 EIF4B SSX2IP NAV2 NAV1 KMT2A BOD1L1 FGD6 PHLDB2

1.40e-208611212936931259
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

RBM15 RAD18 BRIP1 TCOF1 MAP4 BCLAF1 PHF12 PHRF1 DAB2 GPRIN1 PRDM2 YEATS2 TLE3 TLE4 SIPA1L1 BRPF1 EIF4B MKI67 TMPO KMT2A PHLDB2

3.18e-137741212115302935
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

ANKS6 CDC42BPA ANK3 TCOF1 PODXL BCLAF1 ZDHHC5 MUC16 SPECC1L GPRIN1 GAB2 CEP350 ARHGAP1 PTPN13 BBX BAIAP2L1 WDR11 WASF2 MKI67 TMPO ZFHX3

3.43e-137771212135844135
Pubmed

E-cadherin interactome complexity and robustness resolved by quantitative proteomics.

DAB2IP ANK3 MAP4 MARK3 SH3GL1 ZDHHC5 SORBS1 GPRIN1 DENND4C EPN2 ARHGAP1 BAIAP2L1 SYNJ2 WASF2 EIF4B NAV2 TMPO PHLDB2

1.29e-125651211825468996
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

RAF1 ZNF536 RAD18 MAP1A TCOF1 ATXN7L1 PHF12 PHRF1 MCC DCAF5 C2CD2L YEATS2 ATXN1 SIPA1L1 BRPF1 SSX2IP MLLT1 ZFHX3 NUP188 AFF4 WWC1 PHLDB2 BRWD1

5.90e-1211161212331753913
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

DAB2IP ZNF536 MARK3 SORBS1 DCAF5 C2CD2L GRAMD1B USP31 PLEKHG1 YEATS2 TLE3 TLE4 SIPA1L1 NAV1 BOD1L1

1.43e-114071211512693553
Pubmed

A human MAP kinase interactome.

RALGDS CDC42BPA ANK3 MAP1A DAB2 SORBS1 SPECC1L GAB2 CEP350 RGL1 KMT2C ATXN1 SYNJ2 ARHGAP31 NAV2 NAV1

1.54e-114861211620936779
Pubmed

The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.

DAB2IP RAF1 ANKS6 CDC42BPA PODXL MARK3 ZDHHC5 EPN2 SLC4A2 BAIAP2L1 ARHGAP31 MICAL2 WASF2 NAV2 NAV1 FGD6 PHLDB2

1.56e-115691211730639242
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

SMG1 RALGDS CDC42BPA USP28 BCLAF1 PHF12 PHRF1 HECTD4 SPG11 IVNS1ABP KMT2C ZNF532 SYNJ2 ARHGAP31 NAV2 NUP188

5.41e-115291211614621295
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

CDC42BPA KIF1A MAP4 MARK3 PHF12 PHRF1 SPECC1L EPN2 C2CD2L KMT2C PTPN13 BBX STX18 WDR11 WASF2 SIPA1L1 EIF4B KCTD3 KMT2A MLLT1 ZFHX3 TRMT1L HDGFL2 AFF4

3.34e-1014971212431527615
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

CDC42BPA ANK3 MAP1B TCOF1 MAP4 MARK3 BCLAF1 ZDHHC5 GPRIN1 DENND4C ARHGAP1 PTPN13 BAIAP2L1 WASF2 EIF4B TMPO BOD1L1

4.53e-107081211739231216
Pubmed

Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.

MAP1A MAP4 CEP350 YEATS2 ATXN1 ARHGAP31 SIPA1L1 MKI67 NAV1 PHLDB2

1.02e-091841211032908313
Pubmed

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.

RAF1 RBM15 CDC42BPA TCOF1 MAP4 MARK3 BCLAF1 SH3GL1 SPECC1L MICAL2 WASF2 SIPA1L1 EIF4B MKI67 TMPO MLLT1 TRMT1L POLD3 AFF4 WWC1 PHLDB2

2.09e-0912471212127684187
Pubmed

Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

ATXN7L1 GRAMD1B USP31 PLEKHG1 YEATS2 ARHGAP31 TLE4 NAV1

3.06e-09103121810574462
Pubmed

A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.

DAB2IP RAF1 RAD18 ANKS6 TCOF1 BCLAF1 DAB2 DENND4C GAB2 CEP350 LPIN1 ARHGAP1 HAUS8 AP1B1 EIF4B SSX2IP KCTD3 POLD3 WWC1

3.51e-0910381211926673895
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

MAP1A MAP1B TCOF1 MAP4 USP28 BCLAF1 SH3GL1 GPRIN1 YEATS2 PTPN13 WASF2 EIF4B MKI67 TMPO KMT2A BOD1L1 HDGFL2 AFF4

4.28e-099341211833916271
Pubmed

A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.

SMG1 CDC42BPA PODXL SH3GL1 ZDHHC5 DAB2 DENND4C USP31 ARHGAP1 PTPN13 AP1B1 BAIAP2L1 SYNJ2 NAV1 GALNT5 FGD6

4.51e-097191211635337019
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

ZNF536 MAGEB2 BRIP1 MCC SPG11 DENND4C SLC4A2 C2CD2L CEP350 YEATS2 HAUS8 SYNJ2 NAV1 BOD1L1 POLD3 USP1

5.92e-097331211634672954
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

RAF1 RBM15 MARK3 SORBS1 DENND4C PLEKHG1 PTPN13 AP1B1 SIPA1L1 SSX2IP NAV1 WWC1 PHLDB2

5.97e-094461211324255178
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

PHF12 SH3GL1 SORBS1 CEP350 RIMBP3 PLEKHG1 ARHGAP1 HAUS8 BAIAP2L1 WDR11 SYNJ2 WASF2 SIPA1L1 BRPF1 EIF4B SSX2IP BRWD1

7.33e-098531211728718761
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

ANK3 MAP1B TCOF1 MAP4 BCLAF1 SH3GL1 SPECC1L GPRIN1 YEATS2 KMT2C PTPN13 TMPO KMT2A BOD1L1

8.17e-095491211438280479
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

CDC42BPA ANK3 KIF1A MAP1B MAP4 ATXN7L1 MARK3 HECTD4 KATNAL1 YEATS2 KMT2C PTPN13 ZNF532 WDR11 ATXN1 SYNJ2 MICAL2 TLE3 NAV1 ZFHX3 BOD1L1 AFF4

8.93e-0914891212228611215
Pubmed

Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.

CDC42BPA ANK3 MARK3 ZDHHC5 DAB2 GPRIN1 C2CD2L PTPN13 BAIAP2L1 ARHGAP31 WASF2 TMPO

8.96e-093771211238117590
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

RBM15 FLT1 ANK3 SPG11 SORBS1 GPRIN1 KMT2C EIF4B NAV2 TMPO KMT2A GALNT5 HDGFL2

2.14e-084971211336774506
Pubmed

Human transcription factor protein interaction networks.

SMG1 ZNF536 RAD18 CDC42BPA ATXN7L1 PHF12 DCAF5 PRDM2 YEATS2 KMT2C BBX ATXN1 TLE3 TLE4 MKI67 KMT2A MLLT1 ZFHX3 TRMT1L FOXL1 CBX2

2.24e-0814291212135140242
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

RAF1 ANK3 MAP1A MAP1B MAP4 MARK3 BCLAF1 SH3GL1 SORBS1 SPECC1L EPN2 GRAMD1B USP31 AP1B1 MICAL2 SIPA1L1 VCAN EIF4B NAV1 TMPO KMT2A

2.29e-0814311212137142655
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

DAB2IP RBM15 CDC42BPA ANK3 ZDHHC5 GPRIN1 CEP350 USP31 ARHGAP1 PTPN13 WDR11 TLE3 SSX2IP KCTD3 MKI67 TMPO USP1 CBX2

2.53e-0810491211827880917
Pubmed

Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.

RAF1 ZNF536 PHF12 DENND4C PRDM2 YEATS2 PTPN13 ZNF532 TLE3 TLE4 NAV1 ZFHX3

2.79e-084181211234709266
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

RAD18 BRIP1 PHF12 PRDM2 BBX BRPF1 MKI67 TMPO KMT2A BOD1L1 HDGFL2 AFF4 CBX2 BRWD1

2.92e-086081211436089195
Pubmed

An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.

DAB2IP RAF1 ANKS6 ANK3 MCC PCARE XRCC4 DENND4C GAB2 EPN2 IVNS1ABP HAUS8 PTPN13 BBX STX18 SIPA1L1 KCTD3 NAV1 FGD6 PHLDB2

3.11e-0813211212027173435
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

RBM15 RAD18 BRIP1 MAP1B MAP4 BCLAF1 YEATS2 BBX EIF4B MKI67 TMPO KMT2A MLLT1 BOD1L1 HDGFL2 AFF4 CBX2

3.74e-089541211736373674
Pubmed

Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.

CDC42BPA ANK3 TCOF1 MARK3 BCLAF1 ZDHHC5 SPG11 GPRIN1 DCAF5 SLC4A2 GRAMD1B USP31 PLEKHG1 ARHGAP1 PTPN13 STX18 WDR11 SSX2IP TMPO DNAJB2 HDGFL2

4.40e-0814871212133957083
Pubmed

Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.

RALGDS PHF20 MARK3 SH3GL1 SORBS1 EPN2 BBX WDR11 WASF2 SIPA1L1 EIF4B ZFHX3 WWC1

5.17e-085361211315840001
Pubmed

Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.

RAF1 MAP4 SPECC1L PRDM2 YEATS2 KMT2C SIPA1L1 KMT2A BOD1L1

5.21e-08208121933230847
Pubmed

Exchangeable gene trap using the Cre/mutated lox system.

RALGDS PHF20 MARK3 SH3GL1 SORBS1 EPN2 BBX WDR11 WASF2 SIPA1L1 EIF4B ZFHX3 WWC1

5.39e-085381211310512203
Pubmed

Interactomes of Glycogen Synthase Kinase-3 Isoforms.

MAP1A DAB2 DENND4C CEP350 PTPN13 BAIAP2L1 SIPA1L1 SSX2IP WWC1

5.43e-08209121936779422
Pubmed

Phosphoproteome analysis of the human mitotic spindle.

RAD18 MAP4 BCLAF1 PHF12 CENPU CEP350 SSX2IP MKI67 KMT2A

5.66e-08210121916565220
Pubmed

Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.

MAP4 BCLAF1 BBX MKI67 TMPO ZFHX3 BOD1L1 TRMT1L HDGFL2 AFF4

6.21e-082831211030585729
Pubmed

Charting the landscape of tandem BRCT domain-mediated protein interactions.

RAD18 TCOF1 BCLAF1 PHF12 ZDHHC5 CENPU ZNF280B CEP350 AP1B1 TLE4 MKI67 TMPO NUP188 TRMT1L

9.65e-086701211422990118
Pubmed

Comprehensive identification of phosphorylation sites in postsynaptic density preparations.

MAP1A MAP1B BCLAF1 SORBS1 GPRIN1 C2CD2L SIPA1L1 TMPO BRWD1

1.28e-07231121916452087
Pubmed

RIM-BP3 is a manchette-associated protein essential for spermiogenesis.

RIMBP3 RIMBP3C RIMBP3B

1.64e-074121319091768
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

DAB2IP RBM15 RAD18 TCOF1 MAP4 BCLAF1 DAB2 DENND4C TLE3 MKI67 NAV2 PHLDB2

2.07e-075031211216964243
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

DAB2IP RAD18 ANK3 MAP4 COX18 DCAF5 PRDM2 KMT2C PTPN13 TLE4 SIPA1L1 VCAN EIF4B BOD1L1 NUP188 AFF4 BRWD1

2.30e-0710841211711544199
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

MAP1A MAP1B MAP4 BCLAF1 SH3GL1 SPECC1L CEP350 ARHGAP1 HAUS8 PTPN13 SYNJ2 BRPF1 EIF4B MKI67

2.47e-077241211436232890
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

DAB2IP ANK3 TCOF1 USP28 BCLAF1 HECTD4 MCC SORBS1 SPECC1L AP1B1 WASF2 SIPA1L1 NAV1 FRMPD3 AFF4 PHLDB2

2.50e-079631211628671696
Pubmed

Overlapping Activities of Two Neuronal Splicing Factors Switch the GABA Effect from Excitatory to Inhibitory by Regulating REST.

CDC42BPA ANK3 KIF1A SORBS1 GRAMD1B MKI67 TMPO

3.46e-07128121730995482
Pubmed

A protein interaction landscape of breast cancer.

RAF1 BRIP1 ANK3 TCOF1 FAM133A USP28 DAB2 SPECC1L MICAL2 MKI67 NAV2 NUP188 TRMT1L

3.53e-076341211334591612
Pubmed

Spatial proteomics reveal that the protein phosphatase PTP1B interacts with and may modify tyrosine phosphorylation of the rhomboid protease RHBDL4.

MAP4 BCLAF1 ZDHHC5 GPRIN1 GRAMD1B ARHGAP1 MKI67 TMPO

3.78e-07191121831177093
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

DAB2IP MAP1A MAP1B MAP4 ZDHHC5 SORBS1 GPRIN1 EPN2 C2CD2L SIPA1L1

4.08e-073471211017114649
Pubmed

Structure and evolution of RIM-BP genes: identification of a novel family member.

RIMBP3 RIMBP3C RIMBP3B

4.09e-075121317855024
Pubmed

Interaction network of human early embryonic transcription factors.

ZNF536 PHF12 PRDM2 KMT2C ATXN1 TLE3 TLE4 MKI67 KMT2A ZFHX3

4.53e-073511211038297188
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

DAB2IP CDC42BPA ANK3 MAP1A MAP1B MAP4 BCLAF1 SH3GL1 SORBS1 GPRIN1 C2CD2L GRAMD1B SIPA1L1 EIF4B NAV1 POLD3 DNAJB2

4.57e-0711391211736417873
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

RBM15 RAD18 PHF20 TCOF1 ZSCAN5A BCLAF1 PHF12 PHRF1 PRDM2 YEATS2 KMT2C BBX MKI67 TMPO KMT2A MLLT1 NUP188 HDGFL2

5.64e-0712941211830804502
Pubmed

The ubiquitin ligase Uhrf2 is a master regulator of cholesterol biosynthesis and is essential for liver regeneration.

MKI67 TMPO KMT2A POLD3 CBX2 BRWD1

5.86e-0786121637253089
Pubmed

Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability.

RAF1 CDC42BPA MARK3 ZDHHC5 EPN2 SLC4A2 C2CD2L ARHGAP1 STX18 TMPO PHLDB2

7.72e-074671211130194290
Pubmed

A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.

BRIP1 MAP1A USP28 DAB2 ARHGAP1 YEATS2 BAIAP2L1 TLE3 MLLT1 TRMT1L HDGFL2

8.56e-074721211138943005
Pubmed

The protein interaction landscape of the human CMGC kinase group.

RAF1 RBM15 FLT1 TCOF1 BCLAF1 CEP350 TLE3 TLE4 SIPA1L1 NAV1 MLLT1 NUP188 AFF4

9.86e-076951211323602568
Pubmed

Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance.

MAP1A MAP1B TCOF1 MAP4 SH3GL1 SORBS1 GPRIN1 EIF4B

1.35e-06226121831452512
Pubmed

Identification of an FMNL2 Interactome by Quantitative Mass Spectrometry.

CDC42BPA MARK3 SH3GL1 GPRIN1 PTPN13 BAIAP2L1

2.01e-06106121638891874
Pubmed

Perinatal lethality of microtubule-associated protein 1B-deficient mice expressing alternative isoforms of the protein at low levels.

MAP1A MAP1B MAP4

2.27e-068121311085878
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

DAB2IP ANK3 MARK3 ZDHHC5 GPRIN1 EPN2 USP31 PTPN13 BAIAP2L1 PHLDB2

2.33e-064211211036976175
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

ANK3 KIF1A TCOF1 USP28 HECTD4 SORBS1 DCAF5 CEP350 ARHGAP1 PTPN13 STX18 ZNF532 MICAL2 SIPA1L1 DNAJB2 AFF4 BRWD1

2.36e-0612851211735914814
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

RAF1 ANK3 MAP1B TCOF1 MAP4 SH3GL1 XRCC4 IVNS1ABP AP1B1 TLE3 WASF2 EIF4B TMPO TRMT1L POLD3 HDGFL2

2.51e-0611491211635446349
Pubmed

Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.

RBM15 MAP1B BCLAF1 XRCC4 DENND4C CEP350 HAUS8 BBX SSX2IP NAV1 KMT2A CBX2

2.78e-066451211225281560
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

RAF1 ANK3 MAP1A TCOF1 DAB2 MCC TEX14 BAIAP2L1 ZNF532 ARHGAP31

2.81e-064301211035044719
Pubmed

Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.

CDC42BPA ANK3 CEP350 PLEKHG1 HAUS8 SIPA1L1 SSX2IP PHLDB2

2.93e-06251121829778605
Pubmed

Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.

RAF1 SMG1 CDC42BPA MAP1B MARK3 BCLAF1 ANKRD36C GRAMD1B AP1B1 KMT2A MLLT1 NUP188 HDGFL2 AFF4

3.62e-069101211436736316
Pubmed

A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription.

KMT2A MLLT1 AFF4

4.84e-0610121320153263
Pubmed

Caspr2 interacts with type 1 inositol 1,4,5-trisphosphate receptor in the developing cerebellum and regulates Purkinje cell morphology.

MAP1A MAP1B MAP4

4.84e-0610121332675284
Pubmed

The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.

ZDHHC5 DAB2 EPN2 YEATS2 SIPA1L1 PHLDB2

5.24e-06125121629467281
Pubmed

Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.

FLT1 MAP1B PODXL ZSCAN5A DCAF5 CEP350 LPIN1 KMT2C SSX2IP RIMBP3C FGD6 CBX2

5.44e-066891211236543142
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

RAF1 TCEA3 RBM15 CDC42BPA TCOF1 MAP4 FAM133A MARK3 BCLAF1 SPECC1L CEP350 AP1B1 MKI67 TMPO KMT2A AFF4 CBX2

5.58e-0613711211736244648
Pubmed

Identification and characterization of rain, a novel Ras-interacting protein with a unique subcellular localization.

RAF1 RALGDS NAV2

6.64e-0611121315031288
Pubmed

Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.

DAB2IP ANK3 MAP1A SORBS1 SPECC1L GPRIN1 AP1B1 SIPA1L1

6.72e-06281121828706196
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

DAB2IP ANKS6 CDC42BPA PHF12 HECTD4 ZDHHC5 C2CD2L PLEKHG1 KMT2C SCN8A NAV2 NAV1 MLLT1 NUP188 CBX2

7.20e-0611051211535748872
Pubmed

Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.

SMG1 MAP1B MAP4 GPRIN1 ARHGAP1 VCAN EIF4B NAV1 TMPO BOD1L1

1.01e-054981211036634849
Pubmed

C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.

ANKS6 CDC42BPA KIF1A SPG11 GPRIN1 DENND4C SLC4A2 PTPN13 STX18 TMPO

1.13e-055041211034432599
Pubmed

Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.

TCOF1 BCLAF1 SORBS1 YEATS2 BAIAP2L1 WASF2 MKI67 TMPO BOD1L1 HDGFL2

1.16e-055061211030890647
Pubmed

The ENL YEATS epigenetic reader domain critically links MLL-ENL to leukemic stem cell frequency in t(11;19) Leukemia.

KMT2A MLLT1

1.20e-052121236435883
Pubmed

Regulation of microtubule-associated protein 1B (MAP1B) subunit composition.

MAP1A MAP1B

1.20e-052121211002287
Pubmed

Gro/TLE enables embryonic stem cell differentiation by repressing pluripotent gene expression.

TLE3 TLE4

1.20e-052121225446531
Pubmed

Two distinct portions of LTG19/ENL at 19p13 are involved in t(11;19) leukemia.

KMT2A MLLT1

1.20e-05212128378076
Pubmed

Interaction of voltage-gated sodium channel Nav1.6 (SCN8A) with microtubule-associated protein Map1b.

MAP1B SCN8A

1.20e-052121222474336
Pubmed

Identification of a novel RAS GTPase-activating protein (RASGAP) gene at 9q34 as an MLL fusion partner in a patient with de novo acute myeloid leukemia.

DAB2IP KMT2A

1.20e-052121214978793
Pubmed

Heterotypic complex formation between subunits of microtubule-associated proteins 1A and 1B is due to interaction of conserved domains.

MAP1A MAP1B

1.20e-052121216996626
Pubmed

The mouse and rat MAP1B genes: genomic organization and alternative transcription.

MAP1A MAP1B

1.20e-05212129615228
Pubmed

Delayed development of nervous system in mice homozygous for disrupted microtubule-associated protein 1B (MAP1B) gene.

MAP1A MAP1B

1.20e-05212129199175
Pubmed

Cloning of human microtubule-associated protein 1B and the identification of a related gene on chromosome 15.

MAP1A MAP1B

1.20e-05212127806212
Pubmed

Ankyrin-G regulates inactivation gating of the neuronal sodium channel, Nav1.6.

ANK3 SCN8A

1.20e-052121216775201
Pubmed

Spliced MLL fusions: a novel mechanism to generate functional chimeric MLL-MLLT1 transcripts in t(11;19)(q23;p13.3) leukemia.

KMT2A MLLT1

1.20e-052121217252016
Pubmed

Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene.

KMT2A MLLT1

1.20e-052121221953510
Pubmed

Cloning of mouse Dab2ip gene, a novel member of the RasGTPase-activating protein family and characterization of its regulatory region in prostate.

DAB2IP DAB2

1.20e-052121216629596
Pubmed

TLE3 and TLE4-coordinated colonic macrophage-CD4+ T cell crosstalk maintains intestinal immune homeostasis.

TLE3 TLE4

1.20e-052121236801171
Pubmed

The Rho GTPase Rif signals through IRTKS, Eps8 and WAVE2 to generate dorsal membrane ruffles and filopodia.

BAIAP2L1 WASF2

1.20e-052121227278019
Pubmed

Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalities.

KMT2A MLLT1

1.20e-052121219029444
Pubmed

Neuronal abnormalities in microtubule-associated protein 1B mutant mice.

MAP1A MAP1B

1.20e-05212128577753
Pubmed

Molecular cloning of microtubule-associated protein 1 (MAP1A) and microtubule-associated protein 5 (MAP1B): identification of distinct genes and their differential expression in developing brain.

MAP1A MAP1B

1.20e-05212122355215
Pubmed

Preferential targeting of Nav1.6 voltage-gated Na+ Channels to the axon initial segment during development.

ANK3 SCN8A

1.20e-052121225874799
Pubmed

Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.

RBM15 BRIP1 ATXN7L1 YEATS2 AP1B1 MLLT1 AFF4

1.34e-05222121737071664
Pubmed

MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia.

KMT2A MLLT1 AFF4

1.45e-0514121320854876
InteractionYWHAG interactions

DAB2IP RAF1 RBM15 CDC42BPA MARK3 BCLAF1 SH3GL1 HECTD4 MCC SORBS1 SPECC1L DENND4C GAB2 EPN2 C2CD2L CEP350 USP31 LPIN1 PLEKHG1 HAUS8 PTPN13 BAIAP2L1 ATXN1 SYNJ2 WASF2 SIPA1L1 EIF4B SSX2IP NAV2 NAV1 KMT2A BOD1L1 FGD6 WWC1 PHLDB2

4.48e-15124812035int:YWHAG
InteractionYWHAH interactions

DAB2IP RAF1 RBM15 CDC42BPA MARK3 SH3GL1 HECTD4 SORBS1 SPECC1L DENND4C GAB2 EPN2 CEP350 IVNS1ABP USP31 PLEKHG1 HAUS8 PTPN13 BAIAP2L1 ATXN1 SYNJ2 WASF2 SIPA1L1 EIF4B SSX2IP NAV2 NAV1 KMT2A BOD1L1 FGD6 WWC1 PHLDB2

3.45e-14110212032int:YWHAH
InteractionSFN interactions

RAF1 MAGEB2 CDC42BPA MAP1A MAP1B MAP4 MARK3 SORBS1 TEX14 DENND4C GAB2 CEP350 USP31 HAUS8 PTPN13 ATXN1 SYNJ2 SIPA1L1 EIF4B NAV2 NAV1 KMT2A FGD6 PHLDB2

2.38e-1269212024int:SFN
InteractionYWHAB interactions

DAB2IP RAF1 CDC42BPA MARK3 HECTD4 MCC SORBS1 DENND4C GAB2 EPN2 CEP350 IVNS1ABP USP31 PTPN13 BAIAP2L1 ATXN1 SYNJ2 WASF2 SIPA1L1 EIF4B SSX2IP NAV2 NAV1 KMT2A FGD6 WWC1 PHLDB2

3.74e-11101412027int:YWHAB
InteractionYWHAQ interactions

DAB2IP RAF1 CDC42BPA MAP4 MARK3 HECTD4 SORBS1 SPECC1L DENND4C GAB2 EPN2 CEP350 IVNS1ABP USP31 PTPN13 ATXN1 SYNJ2 WASF2 SIPA1L1 EIF4B SSX2IP NAV2 NAV1 TMPO KMT2A FGD6 WWC1 PHLDB2

6.28e-11111812028int:YWHAQ
InteractionKCNA3 interactions

RAF1 CDC42BPA ANK3 MAP1B TCOF1 MAP4 MARK3 BCLAF1 ZDHHC5 SPECC1L GPRIN1 DENND4C PRDM2 ARHGAP1 YEATS2 KMT2C PTPN13 BAIAP2L1 WASF2 SIPA1L1 EIF4B TMPO KMT2A BOD1L1

2.77e-1087112024int:KCNA3
InteractionYWHAE interactions

DAB2IP RAF1 RBM15 RAD18 CDC42BPA MAP1B MARK3 MCC SORBS1 DENND4C GAB2 IVNS1ABP USP31 LPIN1 PTPN13 BAIAP2L1 ATXN1 SYNJ2 SIPA1L1 EIF4B SSX2IP NAV2 NAV1 TMPO KMT2A FGD6 WWC1 PHLDB2

8.94e-10125612028int:YWHAE
InteractionRAC1 interactions

DAB2IP RAF1 RBM15 MAGEB2 CDC42BPA ANK3 PODXL MARK3 ZDHHC5 DAB2 GPRIN1 DENND4C SLC4A2 PLEKHG1 ARHGAP1 PTPN13 AP1B1 BAIAP2L1 WDR11 ATXN1 SYNJ2 ARHGAP31 WASF2 TMPO PHLDB2

2.91e-09106312025int:RAC1
InteractionKSR1 interactions

RAF1 MARK3 DENND4C GAB2 PTPN13 SIPA1L1 KCTD3 NAV1 FGD6 PHLDB2

6.49e-0913212010int:KSR1
InteractionH3C1 interactions

RAD18 BRIP1 PHF20 ANK3 GPRIN1 PRDM2 KMT2C BBX ATXN1 TLE3 BRPF1 MKI67 NAV2 TMPO KMT2A MLLT1 ZFHX3 POLD3 HDGFL2 AFF4 WWC1 CBX2

1.55e-0890112022int:H3C1
InteractionCGN interactions

DAB2IP RAF1 DENND4C GAB2 PTPN13 SIPA1L1 KCTD3 NAV1 FGD6 PHLDB2

2.53e-0815212010int:CGN
InteractionYWHAZ interactions

DAB2IP RAF1 RBM15 CDC42BPA MARK3 SH3GL1 HECTD4 MCC SORBS1 DENND4C GAB2 EPN2 IVNS1ABP GRAMD1B USP31 PTPN13 BAIAP2L1 ATXN1 SIPA1L1 EIF4B SSX2IP NAV2 NAV1 KMT2A FGD6 PHLDB2

4.97e-08131912026int:YWHAZ
InteractionPPM1H interactions

DENND4C GAB2 ARHGAP1 PTPN13 WDR11 SIPA1L1 KCTD3 NAV1 PHLDB2

5.18e-081231209int:PPM1H
InteractionARF6 interactions

RAF1 FLT1 CDC42BPA ANK3 MARK3 ZDHHC5 GPRIN1 DENND4C SLC4A2 ARHGAP1 AP1B1 BAIAP2L1 WDR11 ATXN1 WASF2 TMPO ZFHX3

6.79e-0858412017int:ARF6
InteractionSTX7 interactions

RAF1 ANKS6 CDC42BPA ANK3 PODXL MARK3 ZDHHC5 DAB2 GPRIN1 DENND4C EPN2 SLC4A2 C2CD2L ARHGAP1 STX18 BAIAP2L1 WASF2 TMPO

7.02e-0865912018int:STX7
InteractionCDH1 interactions

DAB2IP ANK3 MAP4 MARK3 SH3GL1 ZDHHC5 SORBS1 GPRIN1 DENND4C EPN2 ARHGAP1 BAIAP2L1 SYNJ2 WASF2 EIF4B MKI67 NAV2 TMPO PHLDB2

1.37e-0776812019int:CDH1
InteractionCBY1 interactions

DAB2IP MCC DENND4C GAB2 PTPN13 SIPA1L1 KCTD3 NAV1 FGD6 PHLDB2

1.39e-0718212010int:CBY1
InteractionDENND1A interactions

RAF1 DENND4C GAB2 PTPN13 SIPA1L1 KCTD3 NAV1 PHLDB2

1.59e-071011208int:DENND1A
InteractionUSP7 interactions

RAF1 RBM15 ZNF536 MAGEB2 RAD18 CDC42BPA FAM133A USP28 BCLAF1 PCARE XK PPP1R14D XRCC4 ATXN1 BRPF1 EIF4B NAV2 TMPO TAC3 POLD3 UTY AFF4 PHLDB2 FOXL1 CBX2

1.84e-07131312025int:USP7
InteractionHRAS interactions

DAB2IP RAF1 RALGDS ANKS6 CDC42BPA MARK3 SH3GL1 ZDHHC5 GAB2 EPN2 RGL1 BAIAP2L1 MICAL2 WASF2 NAV2 NAV1 FGD6 PHLDB2

2.89e-0772512018int:HRAS
InteractionNAA40 interactions

RAF1 MAP1A MAP1B TCOF1 MAP4 USP28 BCLAF1 SH3GL1 GPRIN1 YEATS2 PTPN13 WDR11 WASF2 EIF4B MKI67 TMPO KMT2A BOD1L1 HDGFL2 AFF4 FOXL1

2.98e-0797812021int:NAA40
InteractionC11orf52 interactions

DAB2IP CDC42BPA ANK3 MARK3 ZDHHC5 GPRIN1 SLC4A2 USP31 PTPN13 BAIAP2L1 WASF2 PHLDB2

3.52e-0731112012int:C11orf52
InteractionARRB2 interactions

RAF1 RALGDS RAD18 MAP1B TCOF1 BCLAF1 MCC AP1B1 BRPF1 EIF4B TMPO MLLT1 HDGFL2 AFF4

5.40e-0745412014int:ARRB2
InteractionRHOB interactions

DAB2IP CDC42BPA ANK3 MAP1A PODXL MARK3 SH3GL1 ZDHHC5 DAB2 GPRIN1 EPN2 C2CD2L USP31 ARHGAP1 PTPN13 BAIAP2L1 WASF2 SIPA1L1 PHLDB2

5.40e-0784012019int:RHOB
InteractionKCTD3 interactions

DENND4C GAB2 PTPN13 SIPA1L1 KCTD3 NAV1 DNAJB2 FGD6 PHLDB2

6.07e-071641209int:KCTD3
InteractionAFDN interactions

RALGDS CDC42BPA MARK3 ZDHHC5 SORBS1 PTPN13 ATXN1 SIPA1L1 SSX2IP KCTD3 KMT2A PHLDB2

7.27e-0733312012int:AFDN
InteractionCSNK2A1 interactions

RAF1 MAGEB2 RAD18 TCOF1 FAM133A ZSCAN5A BCLAF1 PHRF1 XK ANKRD36C XRCC4 GRAMD1B ATXN1 EIF4B TMPO KMT2A MLLT1 DNAJB2 HDGFL2 CBX2

8.90e-0795612020int:CSNK2A1
InteractionSH3PXD2A interactions

MARK3 DENND4C GAB2 PTPN13 SIPA1L1 KCTD3 NAV1 PHLDB2

9.84e-071281208int:SH3PXD2A
InteractionSIPA1L1 interactions

CENPU DENND4C GAB2 PTPN13 SIPA1L1 KCTD3 MKI67 NAV1 PHLDB2

9.97e-071741209int:SIPA1L1
InteractionSRSF12 interactions

MAGEB2 RAD18 DENND4C GAB2 SIPA1L1 KCTD3 NAV1 PHLDB2

1.11e-061301208int:SRSF12
InteractionSNRNP40 interactions

RAF1 RBM15 RAD18 BRIP1 TCOF1 BCLAF1 PHF12 PHRF1 YEATS2 ZNF532 MKI67 KMT2A ZFHX3 TRMT1L HDGFL2 CBX2

1.21e-0663712016int:SNRNP40
InteractionPLCD4 interactions

TCOF1 BRPF1 MLLT1 AFF4 CBX2

1.22e-06321205int:PLCD4
InteractionLAMTOR1 interactions

RAF1 ANKS6 CDC42BPA KIF1A MARK3 SH3GL1 ZDHHC5 DAB2 SPG11 GPRIN1 DENND4C EPN2 SLC4A2 ARHGAP1 AP1B1 WDR11 FGD6

1.32e-0672212017int:LAMTOR1
InteractionRHOD interactions

CDC42BPA ANK3 PODXL MARK3 ZDHHC5 DAB2 GPRIN1 DENND4C ARHGAP1 PTPN13 STX18 BAIAP2L1 WDR11 WASF2 TMPO

1.58e-0657212015int:RHOD
InteractionNF1 interactions

RAF1 BRIP1 DENND4C GAB2 PTPN13 SIPA1L1 KCTD3 MKI67 NAV1 PHLDB2

1.63e-0623812010int:NF1
InteractionOCLN interactions

DAB2IP CDC42BPA ANK3 MARK3 ZDHHC5 ERGIC2 GPRIN1 SLC4A2 USP31 ARHGAP1 PTPN13 WASF2 SIPA1L1 PHLDB2

1.69e-0650012014int:OCLN
InteractionEBAG9 interactions

CDC42BPA ANK3 MARK3 ZDHHC5 ERGIC2 DENND4C EPN2 ARHGAP1 PTPN13 AP1B1 WDR11

2.01e-0630312011int:EBAG9
InteractionARRB1 interactions

RALGDS MAGEB2 MAP1B TCOF1 BCLAF1 DCAF5 BRPF1 EIF4B KCTD3 TMPO HDGFL2

2.07e-0630412011int:ARRB1
InteractionACTR3 interactions

RAF1 ZNF536 RAD18 SH3GL1 SORBS1 CEP350 PLEKHG1 ATXN1 WASF2 SIPA1L1 TMPO

2.14e-0630512011int:ACTR3
InteractionKIF13B interactions

DENND4C GAB2 PTPN13 SIPA1L1 KCTD3 NAV1 FGD6 PHLDB2

2.16e-061421208int:KIF13B
InteractionINPP5E interactions

DENND4C PTPN13 SIPA1L1 KCTD3 NAV1 PHLDB2

2.44e-06651206int:INPP5E
InteractionCENPA interactions

ZNF536 RAD18 CENPU PRDM2 BBX BRPF1 KMT2A MLLT1 NUP188 HDGFL2 CBX2 BRWD1

2.65e-0637712012int:CENPA
InteractionSRGAP2 interactions

SORBS1 DENND4C GAB2 IVNS1ABP PTPN13 SIPA1L1 KCTD3 NAV1 PHLDB2

2.79e-061971209int:SRGAP2
InteractionRAC3 interactions

DAB2IP CDC42BPA PODXL MARK3 ZDHHC5 GPRIN1 SLC4A2 ARHGAP1 PTPN13 BAIAP2L1 WDR11 SYNJ2 WASF2 TMPO PHLDB2

4.15e-0661912015int:RAC3
InteractionEN1 interactions

ZNF536 DCAF5 KMT2C ATXN1 TLE3 TLE4 KMT2A

4.27e-061101207int:EN1
InteractionCDC25C interactions

MARK3 DENND4C PTPN13 SIPA1L1 KCTD3 NAV1 NUP188 PHLDB2

4.35e-061561208int:CDC25C
InteractionCSNK2B interactions

RAF1 MAGEB2 RAD18 CDC42BPA TCOF1 FAM133A ZSCAN5A BCLAF1 PHRF1 ATXN1 BRPF1 TMPO KMT2A HDGFL2 CBX2

4.66e-0662512015int:CSNK2B
InteractionNUP43 interactions

RBM15 BRIP1 MAP4 BCLAF1 PHF12 PHRF1 PRDM2 YEATS2 BBX ZNF532 MKI67 KMT2A ZFHX3 BOD1L1 TRMT1L

4.66e-0662512015int:NUP43
InteractionPPIA interactions

BRIP1 ANK3 MAP1A MAP1B USP28 DAB2 ANKRD36C GAB2 SLC4A2 ARHGAP1 YEATS2 BBX BAIAP2L1 TLE3 MKI67 MLLT1 TRMT1L HDGFL2

5.18e-0688812018int:PPIA
InteractionUSP21 interactions

MAP4 MARK3 USP28 DENND4C GAB2 SIPA1L1 KCTD3 PHLDB2

5.49e-061611208int:USP21
InteractionZBTB21 interactions

DENND4C GAB2 PTPN13 SIPA1L1 KCTD3 NAV1 FGD6 PHLDB2

5.49e-061611208int:ZBTB21
InteractionCSNK2A2 interactions

RAF1 RAD18 TCOF1 FAM133A ZSCAN5A BCLAF1 PHRF1 ANKRD36C GRAMD1B ATXN1 BRPF1 MKI67 KMT2A TRMT1L HDGFL2 CBX2

5.62e-0671812016int:CSNK2A2
InteractionRTKN interactions

DENND4C GAB2 PTPN13 SIPA1L1 KCTD3 NAV1 PHLDB2

5.73e-061151207int:RTKN
InteractionPLCD3 interactions

RAD18 TCOF1 MCC DCAF5 MLLT1 HDGFL2 AFF4

8.02e-061211207int:PLCD3
InteractionH3C3 interactions

RAD18 BRIP1 PHF12 PRDM2 BBX BRPF1 MKI67 TMPO KMT2A BOD1L1 HDGFL2 AFF4 CBX2

8.11e-0649512013int:H3C3
InteractionNADK interactions

DENND4C GAB2 SIPA1L1 KCTD3 NAV1 PHLDB2

8.24e-06801206int:NADK
InteractionLATS2 interactions

RAF1 RBM15 SORBS1 PLEKHG1 PTPN13 SIPA1L1 SSX2IP NUP188 WWC1 PHLDB2

9.12e-0628912010int:LATS2
InteractionLRFN1 interactions

DENND4C GAB2 PTPN13 SIPA1L1 KCTD3 NAV1 PHLDB2

9.42e-061241207int:LRFN1
InteractionSOX2 interactions

RBM15 ZNF536 CDC42BPA MAP1A MAP1B MARK3 BCLAF1 SPECC1L DCAF5 ARHGAP1 KMT2C ATXN1 TLE3 SIPA1L1 SSX2IP NAV2 TMPO KMT2A MLLT1 ZFHX3 BOD1L1 TRMT1L CBX2

9.68e-06142212023int:SOX2
InteractionMAPRE3 interactions

MAP1A MAP4 MARK3 SPECC1L CEP350 HAUS8 SYNJ2 NAV2 NAV1

9.80e-062301209int:MAPRE3
InteractionGJA1 interactions

CDC42BPA ANK3 MAP1B MARK3 ZDHHC5 ERGIC2 GPRIN1 DENND4C EPN2 SLC4A2 ARHGAP1 PTPN13 EIF4B PHLDB2

9.85e-0658312014int:GJA1
InteractionCDC42 interactions

CDC42BPA ANK3 MAP4 PODXL MARK3 ZDHHC5 ERGIC2 GPRIN1 SLC4A2 IVNS1ABP PLEKHG1 ARHGAP1 PTPN13 BBX BAIAP2L1 WDR11 ARHGAP31 WASF2 SSX2IP KCTD3 MKI67 TMPO

1.01e-05132312022int:CDC42
InteractionPTPN14 interactions

RAF1 PHF20 MARK3 DENND4C PTPN13 SIPA1L1 KCTD3 WWC1

1.10e-051771208int:PTPN14
InteractionDCLK1 interactions

DCAF5 DENND4C GAB2 SIPA1L1 KCTD3 NAV1 PHLDB2

1.10e-051271207int:DCLK1
InteractionRAC2 interactions

DAB2IP RBM15 CDC42BPA PODXL MARK3 ZDHHC5 DAB2 GPRIN1 ARHGAP1 STX18 BAIAP2L1 WDR11 WASF2 TMPO PHLDB2

1.15e-0567412015int:RAC2
InteractionMAST3 interactions

DENND4C GAB2 PTPN13 SIPA1L1 KCTD3 NAV1 PHLDB2

1.22e-051291207int:MAST3
InteractionGSC interactions

ZNF536 KMT2C ATXN1 TLE3 TLE4 ZFHX3

1.34e-05871206int:GSC
InteractionMARCKS interactions

RAF1 CDC42BPA ANK3 PODXL MARK3 ZDHHC5 GPRIN1 ARHGAP1 PTPN13 STX18 AP1B1 BAIAP2L1 WDR11 TMPO

1.39e-0560112014int:MARCKS
InteractionSTX6 interactions

CDC42BPA ANK3 MARK3 ZDHHC5 DAB2 GPRIN1 DENND4C EPN2 ARHGAP1 PTPN13 STX18 AP1B1

1.52e-0544812012int:STX6
InteractionFMNL2 interactions

RAF1 CDC42BPA MARK3 SH3GL1 GPRIN1 PTPN13 AP1B1 BAIAP2L1

1.52e-051851208int:FMNL2
InteractionCDC25B interactions

DENND4C GAB2 SIPA1L1 EIF4B KCTD3 NAV1 PHLDB2

1.56e-051341207int:CDC25B
InteractionKMT2C interactions

PHF20 TCOF1 KMT2C KMT2A BOD1L1 UTY FOXL1

1.56e-051341207int:KMT2C
InteractionANKRD34A interactions

DENND4C GAB2 SIPA1L1 KCTD3 PHLDB2

1.57e-05531205int:ANKRD34A
InteractionARL4C interactions

ANKS6 CDC42BPA PODXL ZDHHC5 GPRIN1 BAIAP2L1 WASF2

1.72e-051361207int:ARL4C
InteractionHNF1B interactions

ZNF536 TCOF1 BCLAF1 KMT2C ATXN1 TLE3 TMPO ZFHX3

1.84e-051901208int:HNF1B
InteractionFGFR4 interactions

RAF1 ANKS6 ZDHHC5 DAB2 SORBS1 GPRIN1 DENND4C EPN2 ARHGAP1 BAIAP2L1 WASF2 KCTD3

1.89e-0545812012int:FGFR4
InteractionFBXO22 interactions

RBM15 FLT1 ANK3 SPG11 SORBS1 GPRIN1 KMT2C EIF4B NAV2 TMPO KMT2A GALNT5 HDGFL2

2.03e-0554012013int:FBXO22
InteractionDENND4C interactions

DENND4C GAB2 PTPN13 SIPA1L1 KCTD3 NAV1 PHLDB2

2.08e-051401207int:DENND4C
InteractionMCAM interactions

CDC42BPA ANK3 MARK3 ZDHHC5 DAB2 GPRIN1 C2CD2L PTPN13 BAIAP2L1 ARHGAP31 WASF2 TMPO

2.33e-0546812012int:MCAM
InteractionTRIM36 interactions

MAP1A MAP4 SPECC1L CEP350 USP31 HAUS8 NAV1

2.49e-051441207int:TRIM36
InteractionTESK2 interactions

DENND4C GAB2 SIPA1L1 KCTD3 NAV1 PHLDB2

2.50e-05971206int:TESK2
InteractionTERF2IP interactions

ZNF536 RAD18 BRIP1 USP28 XRCC4 YEATS2 BBX MKI67 KMT2A BOD1L1 POLD3 AFF4 CBX2

2.56e-0555212013int:TERF2IP
InteractionVPS33B interactions

ANK3 CEP350 PLEKHG1 ATXN1 WASF2 SIPA1L1 SSX2IP PHLDB2

2.57e-051991208int:VPS33B
InteractionRHOA interactions

RBM15 CDC42BPA ANK3 PODXL MARK3 ZDHHC5 DAB2 ERGIC2 GPRIN1 SLC4A2 GRAMD1B ARHGAP1 PTPN13 STX18 BAIAP2L1 WDR11 ARHGAP31 MKI67 TMPO PHLDB2

2.61e-05119912020int:RHOA
InteractionUHRF2 interactions

BCLAF1 ATXN1 MKI67 TMPO KMT2A POLD3 CBX2 BRWD1

2.66e-052001208int:UHRF2
InteractionFLOT1 interactions

RAF1 RAD18 CDC42BPA ANK3 MARK3 ZDHHC5 SORBS1 GPRIN1 PTPN13 BOD1L1 NUP188 PHLDB2

2.70e-0547512012int:FLOT1
InteractionFEV interactions

PHF12 KMT2C ATXN1 TLE3 TLE4 KMT2A ZFHX3 CBX2

2.96e-052031208int:FEV
InteractionLAMP1 interactions

RAF1 CDC42BPA MARK3 ZDHHC5 GPRIN1 DENND4C EPN2 SLC4A2 ARHGAP1 PTPN13 STX18 BAIAP2L1 WDR11 TMPO

2.97e-0564412014int:LAMP1
InteractionTMEM17 interactions

ANK3 PODXL MARK3 ZDHHC5 EPN2 ARHGAP1 PTPN13 AP1B1 BAIAP2L1 WDR11 WASF2

3.01e-0540412011int:TMEM17
InteractionNUP93 interactions

RAF1 FLT1 MAP1B CENPU PLEKHG1 WDR11 ATXN1 ARHGAP31 NUP188

3.38e-052691209int:NUP93
InteractionXRCC6 interactions

RAF1 FLT1 MAP1B MAP4 BCLAF1 PHRF1 CENPU XRCC4 BBX MKI67 TMPO KMT2A ZFHX3 BOD1L1 TRMT1L HDGFL2 AFF4

3.55e-0592812017int:XRCC6
InteractionPOLR1G interactions

MAGEB2 TCOF1 MCC PRDM2 BBX BRPF1 KMT2A MLLT1 NUP188 TRMT1L AFF4 CBX2

3.58e-0548912012int:POLR1G
InteractionRAB35 interactions

DAB2IP CDC42BPA ANK3 MARK3 ZDHHC5 GPRIN1 DENND4C SLC4A2 C2CD2L ARHGAP1 PTPN13 BAIAP2L1 WASF2

3.76e-0557312013int:RAB35
InteractionRHOC interactions

RAF1 PODXL ATXN7L1 MARK3 ZDHHC5 ARHGAP1 PTPN13 STX18 BAIAP2L1 WDR11 TMPO KMT2A PHLDB2

4.57e-0558412013int:RHOC
InteractionRHOF interactions

CDC42BPA ANK3 PODXL MARK3 ZDHHC5 DAB2 GPRIN1 DENND4C SLC4A2 ARHGAP1 PTPN13 BAIAP2L1 WDR11 TMPO

4.80e-0567312014int:RHOF
InteractionFAM110B interactions

DENND4C GAB2 SIPA1L1 KCTD3 PHLDB2

4.95e-05671205int:FAM110B
InteractionSYDE1 interactions

DENND4C GAB2 SIPA1L1 KCTD3 NAV1 PHLDB2

5.08e-051101206int:SYDE1
InteractionLIMA1 interactions

RAD18 ZDHHC5 DAB2 DENND4C GAB2 WASF2 SIPA1L1 KCTD3 MKI67 NAV1 PHLDB2

5.19e-0542912011int:LIMA1
InteractionFAM53C interactions

DENND4C GAB2 SIPA1L1 KCTD3 PHLDB2

5.32e-05681205int:FAM53C
InteractionRBBP5 interactions

PHF20 TCOF1 YEATS2 KMT2C ZNF532 MKI67 KMT2A BOD1L1 UTY

5.59e-052871209int:RBBP5
GeneFamilyPHD finger proteins

PHF20 PHF12 PHRF1 KMT2C BRPF1 KMT2A

2.67e-069079688
GeneFamilySuper elongation complex|YEATS domain containing

YEATS2 MLLT1

1.12e-0447921283
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

MAP1B PHRF1 PPP1R14D MKI67 POLD3 WWC1

1.41e-04181796694
GeneFamilyZinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family

PRDM2 KMT2C KMT2A

4.36e-0434793487
GeneFamilyAF4/FMR2 family|Super elongation complex

MLLT1 AFF4

6.65e-0497921280
GeneFamilyUbiquitin specific peptidases

USP28 USP31 USP1

1.88e-0356793366
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

KIF1A GAB2 PLEKHG1 FGD6 PHLDB2

2.08e-03206795682
GeneFamilyWD repeat domain containing|DDB1 and CUL4 associated factors

DCAF5 BRWD1

2.76e-0318792498
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

CDC42BPA PHF20 MAP1B PODXL MARK3 SPG11 SPECC1L XRCC4 CEP350 RGL1 PTPN13 BBX ATXN1 SYNJ2 MICAL2 TLE4 SIPA1L1 ZFHX3 WWC1

1.44e-0885612119M4500
CoexpressionPYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP

BRIP1 CDC42BPA CENPU XK ZNF532 KCTD3 TMPO POLD3 BRWD1

3.20e-071951219M13736
CoexpressionHALLMARK_UV_RESPONSE_DN

CDC42BPA MAP1B DAB2 PRDM2 ATXN1 SYNJ2 SIPA1L1 SCN8A

3.64e-071441218M5942
CoexpressionOSMAN_BLADDER_CANCER_UP

SMG1 BCLAF1 ZDHHC5 CENPU ERGIC2 XRCC4 KMT2C BBX ATXN1 SSX2IP TMPO USP1

3.74e-0740212112M5275
CoexpressionHAMAI_APOPTOSIS_VIA_TRAIL_UP

RAD18 CDC42BPA PODXL BCLAF1 CENPU SPG11 ERGIC2 XRCC4 CEP350 PTPN13 BBX WDR11 MKI67 USP1

2.12e-0665612114M18979
CoexpressionMARTINEZ_TP53_TARGETS_DN

GALR1 ANK3 MAP4 ZDHHC5 LPIN1 PTPN13 STX18 TLE3 MKI67 NAV2 MLLT1 UTY WWC1

5.57e-0661512113M8673
CoexpressionWIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2

MAP1B PODXL MICAL2 NAV2 NAV1

6.67e-06571215M2316
CoexpressionMURARO_PANCREAS_BETA_CELL

CDC42BPA MAP1A KIF1A MAP1B HECTD4 MCC SPECC1L KATNAL1 LPIN1 RGL1 KMT2C BBX EIF4B NAV2 USP1 AFF4

7.54e-0694612116M39169
CoexpressionKOINUMA_TARGETS_OF_SMAD2_OR_SMAD3

DAB2IP SMG1 ANKS6 MARK3 EPN2 SLC4A2 CEP350 IVNS1ABP KMT2C BAIAP2L1 ATXN1 WASF2 DNAJB2 WWC1 PHLDB2

8.17e-0684312115M2356
CoexpressionMARTINEZ_TP53_TARGETS_DN

GALR1 ANK3 MAP4 ZDHHC5 LPIN1 PTPN13 STX18 TLE3 MKI67 NAV2 MLLT1 UTY WWC1

1.16e-0565912113MM1040
CoexpressionGSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN

RAF1 CDC42BPA PRDM2 IVNS1ABP NAV2 NAV1 BOD1L1

1.24e-051661217M6826
CoexpressionBUSSLINGER_GASTRIC_IMMUNE_CELLS

SMG1 RALGDS PHF20 MARK3 BCLAF1 HECTD4 SPG11 DCAF5 PRDM2 CEP350 IVNS1ABP LPIN1 KMT2C BBX ATXN1 EIF4B KMT2A BOD1L1 USP1 BRWD1

1.59e-05149212120M40023
CoexpressionZHONG_PFC_C3_MICROGLIA

DAB2IP ANK3 MAP1A KIF1A MAP1B MAP4 GPRIN1 IVNS1ABP PTPN13 NAV1 WWC1

1.69e-0548812111M39104
CoexpressionRODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP

BCLAF1 CENPU XRCC4 USP31 KMT2C MICAL2 VCAN SSX2IP TMPO BOD1L1 USP1 AFF4 BRWD1

2.98e-0572112113M10237
CoexpressionBILD_CTNNB1_ONCOGENIC_SIGNATURE

SMG1 ZNF532 VCAN BOD1L1 FGD6

3.31e-05791215M7102
CoexpressionGAUTAM_EYE_CHOROID_SCLERA_FIBROBLASTS

CDC42BPA DAB2 LPIN1 RGL1 PTPN13 BBX ZFHX3

3.98e-051991217M43608
CoexpressionCUI_TCF21_TARGETS_2_DN

FLT1 PHF20 ATXN7L1 MCC SORBS1 ERGIC2 DCAF5 GAB2 EPN2 PLEKHG1 KMT2C BBX ARHGAP31 TLE4

4.10e-0585412114M1533
CoexpressionGSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP

SMG1 RAD18 SPECC1L PRDM2 KCTD3 FGD6 AFF4

4.11e-052001217M9449
CoexpressionDAZARD_UV_RESPONSE_CLUSTER_G6

BBX MICAL2 TLE4 MKI67 POLD3 WWC1

5.89e-051451216M1810
CoexpressionCUI_TCF21_TARGETS_2_DN

FLT1 PHF20 ATXN7L1 MCC SORBS1 ERGIC2 DCAF5 GAB2 EPN2 PLEKHG1 KMT2C BBX ARHGAP31 TLE4

6.24e-0588812114MM1018
CoexpressionCHICAS_RB1_TARGETS_SENESCENT

FLT1 CDC42BPA MAP4 CENPU IVNS1ABP BBX SYNJ2 NAV1 TMPO POLD3 USP1

6.38e-0556512111M2125
CoexpressionGRYDER_PAX3FOXO1_ENHANCERS_IN_TADS

ANKS6 PODXL PHF12 MCC DCAF5 SLC4A2 AP1B1 WDR11 ATXN1 TLE3 SIPA1L1 NAV2 NAV1 USP1 PHLDB2

6.52e-05100912115M157
CoexpressionCHICAS_RB1_TARGETS_CONFLUENT

TCEA3 BRIP1 MAP1A MAP1B DAB2 ARHGAP1 NAV2 TAC3 GALNT5 FGD6 FOXL1

6.58e-0556712111M2129
CoexpressionWANG_SMARCE1_TARGETS_UP

MAP1B DAB2 MCC PTPN13 ATXN1 TLE3 SIPA1L1 VCAN

6.85e-052941218M1804
CoexpressionAIZARANI_LIVER_C20_LSECS_3

FLT1 MAP1B DAB2 SORBS1 IVNS1ABP PLEKHG1 NAV1 AFF4

7.02e-052951218M39121
CoexpressionMILI_PSEUDOPODIA

MAP1B DCAF5 GAB2 PHLDB2

7.19e-05481214M17507
CoexpressionNAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN

RAF1 BCLAF1 CENPU PRDM2 IVNS1ABP BBX ATXN1 SIPA1L1 TMPO BOD1L1 AFF4 BRWD1

7.51e-0568012112M41089
CoexpressionDAZARD_RESPONSE_TO_UV_NHEK_DN

CEP350 BBX MICAL2 TLE4 MKI67 POLD3 USP1 WWC1

7.89e-053001218M8702
CoexpressionDODD_NASOPHARYNGEAL_CARCINOMA_UP

SMG1 RBM15 RAD18 BRIP1 CENPU XRCC4 USP31 YEATS2 ZNF532 MICAL2 VCAN SSX2IP KCTD3 MKI67 NAV1 TMPO FGD6 CBX2

8.11e-05140712118M14427
CoexpressionMARTINEZ_RB1_TARGETS_UP

CDC42BPA ANK3 MAP1B ZDHHC5 SORBS1 LPIN1 ARHGAP1 PTPN13 STX18 MKI67 NAV2 WWC1

8.62e-0569012112M12224
CoexpressionMILI_PSEUDOPODIA

MAP1B DCAF5 GAB2 PHLDB2

9.13e-05511214MM824
CoexpressionDUTERTRE_ESTRADIOL_RESPONSE_6HR_UP

BRIP1 CENPU GAB2 USP31 AP1B1 MICAL2 NAV2

9.37e-052281217M2151
CoexpressionBOYAULT_LIVER_CANCER_SUBCLASS_G23_UP

CENPU XK MKI67 USP1

1.06e-04531214M4448
CoexpressionGSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_UP

ANKS6 GALR1 PTPN13 KCTD3 NAV2 NAV1

1.12e-041631216M8905
CoexpressionMITSIADES_RESPONSE_TO_APLIDIN_DN

CDC42BPA PODXL ATXN1 EIF4B MKI67 NUP188 POLD3

1.66e-042501217M11318
CoexpressionGSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP

TCOF1 PHF12 PRDM2 YEATS2 TLE4 EIF4B

1.66e-041751216M8908
CoexpressionMARTINEZ_RB1_TARGETS_UP

CDC42BPA ANK3 MAP1B ZDHHC5 SORBS1 LPIN1 ARHGAP1 PTPN13 STX18 MKI67 NAV2 WWC1

1.68e-0474112112MM1037
CoexpressionGOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN

RALGDS RAD18 ANK3 MAP1A MAP1B HECTD4 DAB2 SORBS1 KATNAL1 PLEKHG1 SCN8A NAV2 NAV1 ZFHX3 PHLDB2

1.72e-04110212115M2369
CoexpressionBROWNE_HCMV_INFECTION_4HR_DN

TCOF1 MCC SPECC1L PRDM2 MICAL2 SCN8A UTY

1.74e-042521217M789
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HGABA

RALGDS ANK3 KIF1A MAP1B XK SORBS1 PRDM2 LPIN1 VCAN SCN8A NAV1 ZFHX3 BOD1L1 FRMPD3 BRWD1

1.79e-04110612115M39071
CoexpressionGSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_DN

PODXL SORBS1 KATNAL1 SYNJ2 NAV2 AFF4

1.87e-041791216M8894
CoexpressionONDER_CDH1_TARGETS_2_UP

MAP1B PODXL DAB2 RGL1 MICAL2 VCAN NAV2

1.96e-042571217M13867
CoexpressionFAN_EMBRYONIC_CTX_OLIG

RALGDS ZNF536 ANK3 MAP1A KIF1A GAB2 PRDM2 SLC4A2 BBX SYNJ2 NAV2 DNAJB2

1.97e-0475412112M39037
CoexpressionRODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP

RAD18 CENPU XRCC4 MICAL2 SIPA1L1 SSX2IP MKI67 TMPO USP1 AFF4 BRWD1

2.01e-0464412111M10501
CoexpressionGRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN

PODXL MCC AP1B1 WDR11 SIPA1L1 NAV2 NAV1 USP1 PHLDB2

2.03e-044381219M227
CoexpressionBENPORATH_CYCLING_GENES

RAD18 ZSCAN5A BCLAF1 CENPU IVNS1ABP HAUS8 TLE3 MKI67 TMPO POLD3 USP1

2.12e-0464812111M8156
CoexpressionGOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN

RALGDS RAD18 ANK3 MAP1A MAP1B HECTD4 DAB2 SORBS1 KATNAL1 PLEKHG1 SCN8A NAV2 NAV1 ZFHX3 PHLDB2

2.13e-04112412115MM1070
CoexpressionGSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP

RAF1 CDC42BPA IVNS1ABP MKI67 NAV1 WWC1

2.37e-041871216M6807
CoexpressionGSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_UP

RAF1 CDC42BPA MCC SLC4A2 C2CD2L WWC1

2.37e-041871216M6809
CoexpressionE2F1_UP.V1_UP

RBM15 PHF12 IVNS1ABP TLE4 SSX2IP HDGFL2

2.44e-041881216M2632
CoexpressionCHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP

ANK3 IVNS1ABP VCAN NAV2 PHLDB2

2.50e-041211215M12828
CoexpressionMARTINEZ_RESPONSE_TO_TRABECTEDIN_DN

CDC42BPA ZDHHC5 MICAL2 VCAN EIF4B TMPO POLD3

2.77e-042721217M15123
CoexpressionVEGF_A_UP.V1_DN

FLT1 MAP1B BCLAF1 XRCC4 TLE3 TMPO

2.81e-041931216M2675
CoexpressionMURARO_PANCREAS_ENDOTHELIAL_CELL

DAB2IP FLT1 PODXL DAB2 PLEKHG1 ZNF532 ARHGAP31 MLLT1

2.84e-043621218M39176
CoexpressionHE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL

BRIP1 MAP1B CENPU HAUS8 SYNJ2 VCAN SSX2IP MKI67 FGD6 CBX2

3.06e-0456712110M45692
CoexpressionGSE3982_NEUTROPHIL_VS_TH1_UP

RAF1 MARK3 SORBS1 IVNS1ABP TLE3 SIPA1L1

3.14e-041971216M5532
CoexpressionLAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP

RBM15 RAD18 BRIP1 KIF1A CENPU GPRIN1 SCN8A MKI67 TMPO NUP188 POLD3

3.19e-0468012111MM456
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN

CDC42BPA MAP1B MARK3 SPECC1L XRCC4 CEP350 BBX TLE4 WWC1

3.20e-044661219M13522
CoexpressionGSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN

PTPN13 MICAL2 KMT2A MLLT1 POLD3 FOXL1

3.22e-041981216M5545
CoexpressionGSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN

BRIP1 DAB2 CENPU GAB2 MKI67 TMPO

3.31e-041991216M8031
CoexpressionGSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP

KIF1A SPECC1L TLE4 VCAN POLD3 WWC1

3.31e-041991216M8380
CoexpressionGSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP

MAP4 SH3GL1 PHRF1 SLC4A2 AP1B1 TLE4

3.31e-041991216M3599
CoexpressionGSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_UP

SH3GL1 RGL1 VCAN NAV1 UTY AFF4

3.40e-042001216M5100
CoexpressionGSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_UP

USP28 BCLAF1 C2CD2L ARHGAP31 TRMT1L PHLDB2

3.40e-042001216M9397
CoexpressionFISCHER_G1_S_CELL_CYCLE

BRIP1 ANK3 IVNS1ABP BBX POLD3 USP1

3.40e-042001216M107
CoexpressionGSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN

KATNAL1 PLEKHG1 PTPN13 RIMBP3C NUP188 POLD3

3.40e-042001216M6201
CoexpressionGSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_UP

PRDM2 SIPA1L1 POLD3 DNAJB2 WWC1 CBX2

3.40e-042001216M7340
CoexpressionLASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN

RAF1 RAD18 USP28 SORBS1 PRDM2 ARHGAP1 WDR11 SSX2IP MKI67 KMT2A BOD1L1 POLD3

3.64e-0480712112M14594
CoexpressionCHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP

ANK3 IVNS1ABP VCAN NAV2 PHLDB2

3.74e-041321215MM465
CoexpressionLINDGREN_BLADDER_CANCER_CLUSTER_1_DN

MAP1A DAB2 CENPU C2CD2L RGL1 AP1B1 NAV2 TMPO

3.80e-043781218M17788
CoexpressionHE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL

TCEA3 RBM15 BRIP1 TCOF1 CENPU ANKRD36C HAUS8 AP1B1 MKI67 NUP188 POLD3 USP1 HDGFL2

4.08e-0493912113M45768
CoexpressionMEBARKI_HCC_PROGENITOR_FZD8CRD_UP

RAD18 TCOF1 CENPU GPRIN1 HAUS8 ARHGAP31 TLE3 MKI67 TMPO NUP188

4.08e-0458812110M38992
CoexpressionCHANDRAN_METASTASIS_UP

SMG1 SPG11 ARHGAP1 KMT2C VCAN BOD1L1

4.29e-042091216M16036
CoexpressionBURTON_ADIPOGENESIS_12

PHF12 MKI67 BOD1L1

4.32e-04321213M1558
CoexpressionRODRIGUES_THYROID_CARCINOMA_DN

ANK3 BBX ATXN1 PHLDB2

4.74e-04781214M9814
CoexpressionMARTINEZ_RB1_AND_TP53_TARGETS_DN

GALR1 ANK3 MAP4 PTPN13 STX18 TLE3 MKI67 NAV2 MLLT1 WWC1

5.42e-0461012110M3854
CoexpressionPILON_KLF1_TARGETS_UP

FLT1 RAD18 ANK3 PODXL DAB2 XK KMT2A DNAJB2 WWC1

5.56e-045031219M2226
CoexpressionBMI1_DN_MEL18_DN.V1_UP

PODXL GAB2 C2CD2L NAV2 KMT2A

5.74e-041451215M2779
CoexpressionMILI_PSEUDOPODIA_CHEMOTAXIS_UP

MAP1B DCAF5 GAB2 PHLDB2

6.27e-04841214M15130
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN

CDC42BPA ATXN1 SYNJ2 ZFHX3

6.27e-04841214M13008
CoexpressionONDER_CDH1_SIGNALING_VIA_CTNNB1

MAP1B PODXL MICAL2 VCAN

6.27e-04841214M15484
CoexpressionWHITFIELD_CELL_CYCLE_S

RAD18 BRIP1 CENPU ANKRD36C USP1

6.70e-041501215M2075
CoexpressionAtlasfacebase_RNAseq_e10.5_OlfacPit_2500_K0

ZNF536 ANK3 KIF1A MAP1B CENPU IVNS1ABP GRAMD1B LPIN1 PLEKHG1 HAUS8 BAIAP2L1 SSX2IP NAV2 NAV1 ZFHX3 USP1 UTY CBX2

4.51e-0692612018facebase_RNAseq_e10.5_OlfacPit_2500_K0
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4

SMG1 ZNF536 PHF20 KIF1A MAP1B PHF12 PRDM2 EPN2 MICAL2 SIPA1L1 SSX2IP MKI67 TMPO BOD1L1

6.91e-0659512014Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlasDevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000

DAB2IP SMG1 RAD18 PHF20 MAP4 BCLAF1 DAB2 RGL1 KMT2C ARHGAP31 TLE3 NAV2 NAV1 ZFHX3 GALNT5 UTY

1.15e-0580112016gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlasfacebase_RNAseq_e9.5_OlfPlac_2500_K3

RAF1 ANK3 MAP1B TCOF1 PODXL ZDHHC5 CENPU ZNF280B SLC4A2 PTPN13 AP1B1 BAIAP2L1 TLE4 SSX2IP NAV2 NAV1 ZFHX3 USP1 CBX2

3.68e-05118712019facebase_RNAseq_e9.5_OlfPlac_2500_K3
CoexpressionAtlasfacebase_RNAseq_e10.5_NeuroEpith_central_2500_K4

ZNF536 RAD18 CDC42BPA MAP1A KIF1A MAP1B USP28 BCLAF1 PHF12 CENPU XK ZNF280B TLE3 TLE4 SCN8A MKI67 BOD1L1 POLD3 CBX2 BRWD1

8.12e-05137012020facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_MedNas_2500_K1

PHF20 MAP1A KIF1A MAP1B PODXL USP28 BCLAF1 CENPU XK KATNAL1 TLE4 SSX2IP SCN8A MKI67 BOD1L1 USP1 BRWD1

9.65e-05106012017facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIF1A MAP1B KMT2C NAV2 KMT2A BOD1L1 UTY AFF4 PHLDB2

3.33e-0919512193e519cffa6144a62b06124642a14c9ff39b76554
ToppCellnucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

FLT1 CDC42BPA PODXL MCC SORBS1 PLEKHG1 ARHGAP31 KCTD3

5.02e-081891218b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCellfacs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 PODXL DAB2 EPN2 PLEKHG1 RGL1 ARHGAP31 NAV1

6.38e-08195121812ba6d95e42d06b1991b011043c0e3370a7b4131
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIF1A MAP1B KMT2C NAV2 KMT2A BOD1L1 UTY PHLDB2

6.38e-0819512187796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell(03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition

CDC42BPA MAP1B BCLAF1 ERGIC2 CEP350 BBX BOD1L1 BRWD1

7.47e-081991218c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCellmild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SMG1 BCLAF1 PRDM2 CEP350 KMT2C KMT2A BOD1L1 AFF4

7.76e-08200121812f1685ce8f218433068e090c9d839cd5a1910bf
ToppCellNon-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster

BRIP1 CENPU IVNS1ABP BBX MKI67 TMPO POLD3 USP1

7.76e-0820012184923d7a4f00853c4d76fc1cc0fa82d522a2302e7
ToppCellNon-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster

BRIP1 CENPU IVNS1ABP BBX MKI67 TMPO POLD3 USP1

7.76e-082001218dc1c1506823eaa105f1532c6b5d4efa14e788314
ToppCellCOVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type

FLT1 CDC42BPA PODXL MCC PLEKHG1 SYNJ2 ARHGAP31

6.05e-0717912172a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCellControl-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations)

FLT1 PODXL MCC SORBS1 PLEKHG1 ARHGAP31 KCTD3

6.28e-071801217b043f9ffb9a4cd427a15bebb86a711c7b08866e8
ToppCelldroplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DAB2IP FLT1 MAP4 PODXL PRDM2 PLEKHG1 KMT2A

6.28e-071801217dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCellFetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FLT1 PODXL MCC SORBS1 USP31 PLEKHG1 NAV1

6.28e-071801217d8ef44710a77ad0fc03243428e5e1dc4d41200cb
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK3 PTPN13 BAIAP2L1 MICAL2 NAV2 GALNT5 WWC1

6.28e-071801217b798a3fa2dd15b68aa4267f665559527043dcc07
ToppCelldroplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DAB2IP FLT1 MAP4 PODXL PRDM2 PLEKHG1 KMT2A

6.28e-071801217423454e3390080ae03bb3cbb267255ebfe4df080
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GALR1 DAB2 MCC ARHGAP31 TLE4 ZFHX3 PHLDB2

6.76e-07182121772e65a23cd36085bc880087d3cae92395de918a1
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GALR1 DAB2 MCC ARHGAP31 TLE4 ZFHX3 PHLDB2

6.76e-07182121705c167158815bf25d509df59ab386e1990712765
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK3 PTPN13 BAIAP2L1 MICAL2 NAV2 GALNT5 WWC1

7.27e-071841217ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK3 PTPN13 BAIAP2L1 MICAL2 NAV2 GALNT5 WWC1

7.54e-071851217fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK3 PTPN13 BAIAP2L1 MICAL2 NAV2 GALNT5 WWC1

7.82e-071861217e83718fabb057100835d3357df407f283d23fe16
ToppCell-Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZNF536 ANK3 SPECC1L IVNS1ABP RGL1 ARHGAP31 KMT2A

8.40e-0718812176468fa95ad0395395301115286f2d8c0df5d3882
ToppCell-Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZNF536 ANK3 SPECC1L IVNS1ABP RGL1 ARHGAP31 KMT2A

8.40e-0718812177a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell-Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZNF536 ANK3 SPECC1L IVNS1ABP RGL1 ARHGAP31 KMT2A

8.40e-0718812179cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK3 PTPN13 BAIAP2L1 MICAL2 NAV2 GALNT5 WWC1

8.40e-0718812174bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCellControl-Endothelial_cells|Control / group, cell type (main and fine annotations)

FLT1 PODXL MCC SORBS1 PLEKHG1 ARHGAP31 NAV1

8.40e-0718812173953b08abfea93468fc8d177bdb16ca7c6ffa1ab
ToppCellControl-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FLT1 PODXL MCC SORBS1 PLEKHG1 ARHGAP31 TLE4

8.71e-0718912175d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 BRIP1 CENPU ANKRD36C PLEKHG1 MKI67 NAV1

9.02e-07190121731de1727822e9818652946dfb962daee77ffad68
ToppCellLPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

CDC42BPA PODXL MCC USP31 PLEKHG1 ARHGAP31 TLE4

9.02e-071901217474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCellfacs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 PODXL DAB2 PLEKHG1 RGL1 ARHGAP31 NAV1

9.34e-0719112171924af7d8b0a0b892e480a9fd6d874941b0c0b5d
ToppCellfacs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 PODXL DAB2 PLEKHG1 RGL1 ARHGAP31 NAV1

9.34e-07191121788f91e57a1409bdeb91e9bf47510a6fb998a1bf5
ToppCellfacs-BAT-Fat-18m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DAB2IP FLT1 PODXL MCC SORBS1 EPN2 ARHGAP31

9.67e-0719212173a99c521c599a289ee2309d97be5ceb99f8aa220
ToppCellfacs-BAT-Fat-18m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DAB2IP FLT1 PODXL MCC SORBS1 EPN2 ARHGAP31

9.67e-071921217f9777e0fdd86c2a514f05a42502888329a94b396
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

SMG1 ANK3 ANKRD36C IVNS1ABP KMT2C KMT2A UTY

9.67e-07192121747646d7e4990be85072987f92bf18d52f8da752e
ToppCellfacs-BAT-Fat-18m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DAB2IP FLT1 PODXL MCC SORBS1 EPN2 ARHGAP31

9.67e-071921217562e15876088af9189744c9b2de5c4863d7f15fd
ToppCellnucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

FLT1 PODXL MCC SORBS1 PLEKHG1 ARHGAP31 NAV1

1.00e-061931217f582e939e3e08a8a3f71deec78c33715be8faa51
ToppCellControl-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FLT1 PODXL MCC SORBS1 PLEKHG1 ARHGAP31 TLE4

1.00e-061931217aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCellControl-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FLT1 PODXL MCC SORBS1 PLEKHG1 ARHGAP31 TLE4

1.00e-061931217c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCellLPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PODXL MCC SORBS1 USP31 PLEKHG1 ARHGAP31 TLE4

1.00e-061931217a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

ZNF536 BRIP1 CENPU HAUS8 MKI67 NAV2 FOXL1

1.00e-061931217516ea2c12bdc7a5dc676159d627e36f6abe13ef0
ToppCellnucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

FLT1 PODXL MCC SORBS1 PLEKHG1 ARHGAP31 NAV1

1.00e-061931217ad3f4fcc8e2816d696cbcde744dc16500e51ccac
ToppCellfacs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 PODXL DAB2 PLEKHG1 ARHGAP31 NAV1 PHLDB2

1.04e-061941217c8b9551b93a5aed62154b487db90130604a6125c
ToppCelldroplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DAB2IP FLT1 BCLAF1 SORBS1 PRDM2 ARHGAP31 WASF2

1.04e-061941217e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCellLPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FLT1 PODXL MCC USP31 PLEKHG1 ARHGAP31 NAV1

1.04e-06194121758f069efdefa0366033764446b9d6ffd4a17807e
ToppCellLPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FLT1 PODXL MCC USP31 PLEKHG1 ARHGAP31 NAV1

1.04e-061941217bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell(1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class

FLT1 MAP1B DAB2 PLEKHG1 RGL1 AP1B1 ARHGAP31

1.07e-0619512176b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a
ToppCellCV-Moderate-6|CV / Virus stimulation, Condition and Cluster

SMG1 PHF20 CEP350 KMT2C KMT2A BOD1L1 AFF4

1.11e-0619612177bced0cc2112697593c478fa291b8ed3941fb811
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 CDC42BPA PODXL SORBS1 PLEKHG1 ARHGAP31 NAV1

1.11e-061961217d37f714d4fb57e958f3738fdda085560813e5bb5
ToppCellnucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

FLT1 CDC42BPA PODXL MCC SORBS1 PLEKHG1 ARHGAP31

1.11e-061961217686533fd3fba8e4df96b9dd1307e870e89db4332
ToppCellfacs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 DAB2 PLEKHG1 RGL1 ARHGAP31 NAV1 PHLDB2

1.15e-061971217deefb492b5f0e6014144bd465c4a6ae4206e8739
ToppCellfacs-Brain_Non-Myeloid|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 CDC42BPA ANK3 MAP1A KIF1A SORBS1 EPN2

1.15e-061971217a1f7eec1aca03432caa8fe817ff6d24b29d4062d
ToppCellfacs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 DAB2 PLEKHG1 RGL1 ARHGAP31 NAV1 PHLDB2

1.15e-061971217a6aaa6faea348291023f0bc4b0f83fbc67d91da6
ToppCellCOVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type

FLT1 PODXL MCC SORBS1 PLEKHG1 ARHGAP31 NAV1

1.15e-0619712177e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCellmoderate-Epithelial-Secretory|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

TCEA3 CDC42BPA PODXL MUC16 ANKRD36C PTPN13 GALNT5

1.19e-0619812177d96d7105a849c7280ce87bd76ce130ac47384fd
ToppCell3'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

KIF1A MAP1B CENPU GPRIN1 MKI67 TMPO USP1

1.19e-0619812172ee8ac82ef1b8ebabc8dd824211bbb471f2af8ac
ToppCellfacs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 DAB2 PLEKHG1 RGL1 ARHGAP31 NAV1 PHLDB2

1.19e-061981217f0f1816a0ed3ae8207442602f5cbe4de0382e4b3
ToppCellBrain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type.

RALGDS ANK3 KIF1A HECTD4 NAV1 KMT2A ZFHX3

1.27e-062001217c92e4fc0442404481fcac623d691dae6215b852d
ToppCellsystemic_lupus_erythematosus-flare-Lymphocytic_B-B_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

FLT1 TCOF1 PLEKHG1 NAV2 GALNT5 UTY

6.02e-0616512168003fd2aa3f5c9d0e99054af4ad2d79a4a3c4829
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 MAP1B PODXL PLEKHG1 ARHGAP31 NAV1

6.24e-0616612168e5f2afbeffae5e77fcb29e8fe9f5aa49779b619
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

BRIP1 MAP1B CENPU MICAL2 VCAN MKI67

7.39e-061711216b0373ed8283ee1792b6a490bff93906546978593
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

BRIP1 MAP1B CENPU MICAL2 VCAN MKI67

7.39e-061711216b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

CENPU ANKRD36C GPRIN1 HAUS8 MKI67 CBX2

7.90e-06173121620889aa85e36ad3bafdb91b91e43964493c949f9
ToppCelldroplet-Fat-SCAT-30m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 GALR1 PODXL SORBS1 ZNF532 ARHGAP31

7.90e-061731216eb58b0189e71e38d4f4f1cf544a82cde8d1c86bc
ToppCell368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

CENPU ANKRD36C GPRIN1 HAUS8 MKI67 CBX2

7.90e-06173121646e601b7938b1dd0aa3df7aa056c4bd07b1620c1
ToppCellTCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-4|TCGA-Breast / Sample_Type by Project: Shred V9

ANKS6 ZNF280B LPIN1 PLEKHG1 YEATS2 FOXL1

9.29e-06178121644b5ba4e8788d3973749a1717e427647ac4c8579
ToppCellCOVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

FLT1 PODXL MCC SORBS1 IVNS1ABP PLEKHG1

9.59e-061791216754f69bac7a1d5137f5141f6193285ccbfe361cb
ToppCellLPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK3 TEX14 PTPN13 BAIAP2L1 GALNT5 WWC1

9.59e-061791216fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCellCOVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

FLT1 PODXL PLEKHG1 SYNJ2 ARHGAP31 NAV1

9.59e-0617912161ce8d18f63e8dd2d3db41fbeca4601bd3b305fba
ToppCellCOVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

FLT1 PODXL SORBS1 IVNS1ABP USP31 PLEKHG1

9.90e-061801216493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

GALR1 DAB2 MCC ARHGAP31 TLE4 ZFHX3

9.90e-061801216e8841ef1239f9ee73ac4f4e11faca0742694f368
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_2-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK3 PTPN13 BAIAP2L1 MICAL2 GALNT5 WWC1

1.05e-0518212161e2149b222a3e9f64841aed45288a6f29394e7b0
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK3 PTPN13 BAIAP2L1 NAV2 GALNT5 WWC1

1.05e-05182121617ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCellControl-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PODXL MCC SORBS1 PLEKHG1 ARHGAP31 TLE4

1.09e-051831216e81c142770f44fd902b0631bc360c5b5339d4c75
ToppCell5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ZNF536 MAP1B SORBS1 VCAN PHLDB2 FOXL1

1.09e-051831216af8d86f15a549064530d94bd47081daf59d58ecd
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK3 PTPN13 BAIAP2L1 NAV2 GALNT5 WWC1

1.16e-051851216929b68b05b7686341329ac756d7df172cb4b810b
ToppCellFetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ZNF536 SORBS1 SYNJ2 MICAL2 VCAN NAV2

1.16e-051851216e58a009aaf342be019a909747b1895d5987d4daf
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PTPN13 BAIAP2L1 NAV2 GALNT5 WWC1 PHLDB2

1.19e-0518612164e94158db52df41d71e67b02b9895a358eebee0f
ToppCelldroplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DAB2IP FLT1 PODXL CEP350 ARHGAP31 PHLDB2

1.19e-0518612160ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCellControl-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PODXL MCC SORBS1 PLEKHG1 ARHGAP31 TLE4

1.23e-051871216ea9d34bcd3bd1f36745846309ede349773de501a
ToppCellLPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK3 PTPN13 BAIAP2L1 NAV2 GALNT5 WWC1

1.23e-051871216201ff693e4756ee3e44762885b3a303a77eb535b
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PODXL MCC USP31 PLEKHG1 ARHGAP31 TLE4

1.23e-051871216f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1
ToppCellFetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

FLT1 PODXL SORBS1 PLEKHG1 TLE4 FOXL1

1.23e-05187121697b2463fb37e7196dd2f92553acf8e7bc3ec40dd
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PTPN13 BAIAP2L1 NAV2 GALNT5 WWC1 PHLDB2

1.23e-05187121658d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCellControl-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations)

FLT1 PODXL SORBS1 PLEKHG1 ARHGAP31 NAV1

1.23e-051871216fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8
ToppCell10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue

SMG1 BCLAF1 ANKRD36C PRDM2 KMT2C KMT2A

1.27e-051881216ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCellLPS-IL1RA-Epithelial_alveolar|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK3 PTPN13 BAIAP2L1 NAV2 GALNT5 WWC1

1.27e-0518812166164d467b612767ceba15de34176bcc8e8c36ab8
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ANK3 PTPN13 BAIAP2L1 NAV2 GALNT5 WWC1

1.27e-05188121643a0508d2524a5b310e89e9422843dcaab999bc3
ToppCellLPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FLT1 PODXL MCC USP31 PLEKHG1 TLE4

1.27e-051881216789d1be574e693d7bdd488f3c72c6df788e47b47
ToppCellCOVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations)

ANK3 PTPN13 BAIAP2L1 MICAL2 NAV2 WWC1

1.27e-051881216c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 PODXL PLEKHG1 SYNJ2 ARHGAP31 NAV1

1.27e-051881216c2c51c6526defe2600302901159b8abbb58d7595
ToppCellMatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4)

RAD18 BRIP1 CENPU HAUS8 MKI67 TMPO

1.27e-051881216b240ea20750ffb825cb5fe41d06c632233406ab6
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 PODXL PLEKHG1 SYNJ2 ARHGAP31 NAV1

1.31e-0518912166463890d8dbee4bc198f91628a5f784970de786a
ToppCellLPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FLT1 MAP1B PODXL GRAMD1B SYNJ2 NAV1

1.31e-051891216b028466fcd36fdeceec752e55a24286a1cd62ae4
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

ZNF536 PLEKHG1 NAV2 ZFHX3 LINC02694 FOXL1

1.31e-0518912160abc7a4900cc9033bc1be69b770ccc54a6bf41b4
ToppCellIPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class

ANK3 MCC USP31 PTPN13 GALNT5 PHLDB2

1.35e-051901216ea19e9ce954f2dfde97388db9695325cd92ab88f
ToppCellLPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FLT1 MAP1B PODXL GRAMD1B SYNJ2 NAV1

1.35e-051901216aed65d584ca0c25f6a8313c66b421a6618af82ea
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FLT1 PODXL MCC PLEKHG1 ARHGAP31 TLE4

1.35e-051901216a3c6eec6df052105ab78b7e3c78f94218d5912eb
ToppCellLPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FLT1 PODXL MCC USP31 PLEKHG1 ARHGAP31

1.39e-051911216a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FLT1 PODXL PLEKHG1 SYNJ2 ARHGAP31 NAV1

1.43e-051921216bacbaef1f230051335f4433e55db07a161b96b4c
ToppCellfacs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 PODXL DAB2 PLEKHG1 ARHGAP31 NAV1

1.43e-0519212162bfac6b3956265205ca47d06888851ed68b65999
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CDC42BPA MCC GPRIN1 KMT2A POLD3 BRWD1

1.43e-051921216d6f656be2698bd215717d35f4e7ab727c08c61e0
ToppCellfacs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FLT1 PODXL DAB2 PLEKHG1 ARHGAP31 NAV1

1.43e-051921216d525f7f088a53110912600a7c9f6d33b9270d534
DrugChlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A

PHF20 MAP1B MAP4 SORBS1 XRCC4 PRDM2 ATXN1 TMPO KMT2A AFF4

5.95e-08189119103788_DN
DrugNeostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A

RALGDS CDC42BPA MAP4 DAB2 PRDM2 CEP350 BBX KMT2A USP1

6.52e-0718811996735_DN
Drugforskolin; Up 200; 50uM; HL60; HG-U133A

PPP1R14D GAB2 CEP350 IVNS1ABP GRAMD1B MICAL2 TLE3 VCAN SSX2IP

8.13e-071931199783_UP
DrugThimerosal

RAD18 PHF20 KIF1A MAP4 BCLAF1 CENPU ERGIC2 PRDM2 CEP350 ATXN1 TLE4 WASF2 EIF4B KMT2A BOD1L1 FRMPD3 USP1 FGD6 AFF4 PHLDB2 BRWD1

9.85e-07119911921ctd:D013849
Drug2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester

DAB2IP FLT1 ANK3 MAP1B PODXL MCC GAB2 GRAMD1B BAIAP2L1 ATXN1 MICAL2 TLE3 VCAN SSX2IP NAV1 FGD6 WWC1

1.03e-0680711917ctd:C548651
DrugThalidomide [50-35-1]; Down 200; 15.4uM; MCF7; HT_HG-U133A

MAP1B XRCC4 LPIN1 SYNJ2 MICAL2 DNAJB2 FGD6 UTY

7.80e-0619211985990_DN
DrugGlycocholic acid [475-31-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A

CDC42BPA ANK3 MAP4 AP1B1 TLE4 SIPA1L1 DNAJB2 FGD6

8.41e-0619411985316_DN
Drug5279552; Down 200; 22uM; MCF7; HT_HG-U133A_EA

RALGDS CDC42BPA PRDM2 AP1B1 SYNJ2 SSX2IP KMT2A ZFHX3

8.73e-061951198843_DN
DrugLY 294002; Down 200; 10uM; HL60; HT_HG-U133A

CDC42BPA MAP4 XRCC4 EPN2 LPIN1 VCAN WWC1 BRWD1

9.07e-0619611982687_DN
DrugPHA-00745360 [351320-33-7]; Up 200; 10uM; PC3; HT_HG-U133A

FLT1 ZNF280B PRDM2 C2CD2L TLE4 VCAN KMT2A AFF4

9.41e-0619711984559_UP
DrugPicotamide monohydrate [80530-63-8]; Down 200; 10.2uM; PC3; HT_HG-U133A

BRIP1 CDC42BPA MAP4 XRCC4 CEP350 VCAN MKI67 BRWD1

9.41e-0619711982070_DN
DrugFamprofazone [22881-35-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A

BRIP1 PHF20 MCC EPN2 SYNJ2 TLE4 KMT2A NUP188

1.01e-0519911983928_DN
DrugBethanechol chloride [590-63-6]; Down 200; 20.4uM; MCF7; HT_HG-U133A

CDC42BPA MAP4 GAB2 MICAL2 SIPA1L1 FGD6 UTY AFF4

1.01e-0519911985539_DN
Drughaloperidol; Down 200; 10uM; MCF7; HT_HG-U133A

CDC42BPA DENND4C ARHGAP1 TLE4 BRPF1 KMT2A ZFHX3 BRWD1

1.01e-0519911986963_DN
Drugirinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A

EPN2 GRAMD1B YEATS2 ATXN1 SIPA1L1 NAV2 WWC1

3.30e-0517111977535_DN
DrugCamptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A

MARK3 DAB2 PRDM2 CEP350 GRAMD1B NAV2 POLD3

4.57e-0518011974541_DN
DrugICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A

RALGDS TCOF1 MAP4 EPN2 SYNJ2 MICAL2 WWC1

4.90e-0518211971663_DN
DrugSulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A

CDC42BPA MAP4 PRDM2 CEP350 BBX TMPO FGD6

5.43e-0518511971673_DN
Drug0173570-0000 [211245-44-2]; Down 200; 10uM; PC3; HT_HG-U133A

BRIP1 MAP1B MCC XRCC4 TLE3 MKI67 FGD6

6.22e-0518911973690_DN
DrugKetanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A

DAB2 CEP350 BBX SYNJ2 VCAN BRPF1 KMT2A

6.22e-0518911976649_DN
DrugMethapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A

RALGDS MAP4 CEP350 BBX SYNJ2 VCAN KMT2A

6.65e-0519111976644_DN
DrugCyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; HL60; HT_HG-U133A

RALGDS KIF1A TCOF1 MAP4 CEP350 SYNJ2 VCAN

6.87e-0519211971332_UP
DrugNaphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; PC3; HT_HG-U133A

RALGDS CDC42BPA LPIN1 SYNJ2 TLE3 VCAN KMT2A

7.10e-0519311976604_DN
DrugAzaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A

DENND4C EPN2 C2CD2L ARHGAP1 YEATS2 TLE3 KMT2A

7.33e-0519411971670_DN
DrugLynestrenol [52-76-6]; Up 200; 14uM; MCF7; HT_HG-U133A

MAP1B MAP4 XRCC4 MICAL2 SIPA1L1 NAV2 UTY

7.33e-0519411975355_UP
DrugFlutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A

MAP4 CEP350 BBX SYNJ2 KMT2A USP1 CBX2

7.33e-0519411974361_DN
DrugAzathymine, 6 [932-53-6]; Down 200; 31.4uM; MCF7; HT_HG-U133A

PHF20 MAP4 EPN2 ARHGAP1 SIPA1L1 TMPO UTY

7.57e-0519511974106_DN
DrugCephalexin monohydrate [23325-78-2]; Up 200; 11uM; HL60; HT_HG-U133A

FLT1 MAP4 PRDM2 EPN2 SYNJ2 KMT2A UTY

7.57e-0519511971273_UP
DrugBenzathine benzylpenicillin [5928-84-7]; Up 200; 4.2uM; HL60; HT_HG-U133A

CDC42BPA ANK3 DAB2 PPP1R14D EPN2 TAC3 UTY

7.82e-0519611972939_UP
DrugDicloxacillin sodium salt [13412-64-1]; Down 200; 8.2uM; PC3; HT_HG-U133A

RALGDS PHF20 KIF1A TLE3 VCAN WWC1 BRWD1

7.82e-0519611976666_DN
DrugKawain [500-64-1]; Up 200; 17.4uM; MCF7; HT_HG-U133A

CDC42BPA TEX14 PRDM2 LPIN1 SIPA1L1 SSX2IP NAV2

7.82e-0519611974693_UP
DrugPizotifen malate [5189-11-7]; Down 200; 9.4uM; PC3; HT_HG-U133A

CDC42BPA PHF20 GRAMD1B ARHGAP1 VCAN ZFHX3 TRMT1L

7.82e-0519611975072_DN
DrugMethylergometrine maleate [113-42-8]; Down 200; 8.8uM; MCF7; HT_HG-U133A

PHF20 ZSCAN5A SH3GL1 XRCC4 EPN2 YEATS2 BRPF1

8.07e-0519711975303_DN
DrugFK-506; Up 200; 1uM; MCF7; HG-U133A

C2CD2L TLE3 SSX2IP NUP188 FGD6 UTY BRWD1

8.07e-051971197284_UP
DrugBendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A

MAP4 EPN2 SLC4A2 AP1B1 ATXN1 TLE3 FGD6

8.07e-0519711973415_DN
DrugGuanfacine hydrochloride [29110-48-3]; Up 200; 14.2uM; HL60; HT_HG-U133A

CDC42BPA MAP4 XRCC4 EPN2 C2CD2L RGL1 TLE3

8.07e-0519711971279_UP
DrugBAS 012416453; Up 200; 38uM; MCF7; HT_HG-U133A

BRIP1 ZSCAN5A XK XRCC4 ATXN1 SYNJ2 SSX2IP

8.07e-0519711976908_UP
DrugNicergoline; Down 200; 8.2uM; HL60; HG-U133A

CDC42BPA MAP1A IVNS1ABP ARHGAP1 KCTD3 MKI67 TAC3

8.07e-0519711971374_DN
DrugDizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A

MAGEB2 CDC42BPA MAP4 LPIN1 TLE3 VCAN BRWD1

8.07e-0519711975746_DN
DrugNitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; HL60; HT_HG-U133A

FLT1 CDC42BPA MCC PPP1R14D XRCC4 EPN2 KMT2A

8.07e-0519711972188_UP
DrugGlimepiride [93479-97-1]; Up 200; 8.2uM; HL60; HT_HG-U133A

CDC42BPA ANK3 MAP4 PTPN13 VCAN AFF4 WWC1

8.33e-0519811972154_UP
DrugTranexamic acid [1197-18-8]; Up 200; 25.4uM; MCF7; HT_HG-U133A

KIF1A LPIN1 PTPN13 ATXN1 VCAN NUP188 AFF4

8.33e-0519811976238_UP
DrugN6-methyladenosine [1867-73-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A

KIF1A MAP4 XRCC4 ARHGAP1 SYNJ2 SIPA1L1 AFF4

8.33e-0519811972626_DN
DrugAdrenosterone [382-45-6]; Down 200; 13.4uM; HL60; HT_HG-U133A

ANK3 MAP4 ZSCAN5A SH3GL1 C2CD2L SIPA1L1 ZFHX3

8.33e-0519811973107_DN
DrugAcenocoumarol [152-72-7]; Down 200; 11.4uM; PC3; HT_HG-U133A

DAB2 XRCC4 ATXN1 SYNJ2 TMPO KMT2A BRWD1

8.60e-0519911972077_DN
DrugChloropyramine hydrochloride [6170-42-9]; Down 200; 12.2uM; HL60; HT_HG-U133A

PHF20 ANK3 MAP1A MAP4 XRCC4 SYNJ2 ZFHX3

8.60e-0519911973011_DN
DrugCiprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A

CDC42BPA GAB2 CEP350 IVNS1ABP YEATS2 TLE3 UTY

8.87e-0520011975299_DN
DrugSpiramycin [8025-81-8]; Up 200; 4.8uM; HL60; HT_HG-U133A

CDC42BPA MAP4 DAB2 XRCC4 VCAN NAV2 KMT2A

8.87e-0520011972558_UP
DrugMethamphetamine

FLT1 RAD18 MAP1A MAP4 PODXL ATXN7L1 SH3GL1 PHRF1 MCC SORBS1 PRDM2 IVNS1ABP AP1B1 ZNF532 SYNJ2 TLE3 WASF2 MKI67 BRWD1

1.18e-04140111919ctd:D008694
Druggeldanamycin

RAF1 FLT1 MAP1B TLE4 KMT2A BOD1L1 GALNT5 AFF4 PHLDB2

1.47e-043711199ctd:C001277
Drugtestosterone enanthate

SMG1 ANK3 TCOF1 BCLAF1 DAB2 SORBS1 USP31 YEATS2 BBX KMT2A USP1

2.18e-0457511911ctd:C004648
DrugSuccimer

SMG1 RAD18 CDC42BPA ANK3 BCLAF1 DAB2 PRDM2 GRAMD1B ATXN1 MICAL2 MKI67 NAV2 NAV1 TMPO USP1 UTY BRWD1

3.08e-04126411917ctd:D004113
Drugpararosaniline base; Up 200; 10uM; MCF7; HT_HG-U133A_EA

MAP1B XRCC4 LPIN1 ATXN1 NAV2 AFF4

3.41e-041771196893_UP
DrugICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA

CDC42BPA PHF20 CEP350 ATXN1 KMT2A USP1

3.41e-041771196985_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A

ZNF536 MAP4 GRAMD1B TLE3 VCAN TMPO

3.51e-0417811966193_DN
DrugEtifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A

CDC42BPA MAP4 CEP350 BBX KMT2A USP1

3.51e-0417811963998_DN
DrugCaptopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A

CDC42BPA ANK3 MAP4 BBX KMT2A USP1

3.62e-0417911964585_DN
Drugretinoic acid; Down 200; 1uM; HL60; HT_HG-U133A

TCOF1 MAP4 XRCC4 MICAL2 VCAN SSX2IP

3.72e-0418011961152_DN
DrugAC1L1IL4

RAF1 FLT1

4.01e-0461192CID000004625
DrugP-320

FLT1 KMT2A

4.01e-0461192CID000203773
Drugirinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A

BRIP1 PHF20 PRDM2 CEP350 BBX TMPO

4.07e-0418311967498_DN
Drug0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A

BRIP1 HECTD4 SYNJ2 MICAL2 TLE3 TRMT1L

4.31e-0418511964755_DN
DrugNimodipine [66085-59-4]; Up 200; 9.6uM; HL60; HT_HG-U133A

CDC42BPA ANK3 MAP4 SORBS1 SIPA1L1 NUP188

4.31e-0418511963103_UP
DrugNocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A

MAP1B GAB2 LPIN1 ATXN1 SIPA1L1 NAV2

4.43e-0418611966793_UP
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A

MAP1A KIF1A MAP1B SORBS1 TEX14 RGL1

4.56e-0418711965976_UP
DrugDicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A

PHF20 ANK3 MAP4 PRDM2 TMPO KMT2A

4.56e-0418711964323_DN
DrugDicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; PC3; HT_HG-U133A

FLT1 PHF20 ZNF280B C2CD2L VCAN AFF4

4.56e-0418711964581_UP
DrugMagnetite Nanoparticles

SMG1 RAD18 CDC42BPA ANK3 BCLAF1 DAB2 PRDM2 GRAMD1B ATXN1 MICAL2 MKI67 NAV2 NAV1 TMPO USP1 UTY BRWD1

4.64e-04131011917ctd:D058185
DrugNocodazole [31430-18-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A

XRCC4 LPIN1 ATXN1 SIPA1L1 VCAN NAV2

4.69e-0418811962239_UP
DrugPrimaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A

TCOF1 HECTD4 PRDM2 CEP350 KMT2A BRWD1

4.69e-0418811964845_DN
DrugMepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A

CDC42BPA MAP1B MAP4 PRDM2 CEP350 TMPO

4.82e-0418911964304_DN
DrugResveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A

MAP1A XRCC4 VCAN TMPO UTY WWC1

4.82e-0418911965084_DN
Drugpioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A

BRIP1 ANK3 IVNS1ABP SSX2IP FGD6 BRWD1

4.96e-0419011967528_DN
DrugDeltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A

MAP1B MAP4 ATXN7L1 PRDM2 ATXN1 TMPO

4.96e-0419011964306_DN
DrugPempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A

CDC42BPA MAP1B MAP4 CEP350 BBX TMPO

4.96e-0419011964307_DN
DrugEconazole nitrate [24169-02-6]; Down 200; 9uM; PC3; HT_HG-U133A

BRIP1 XRCC4 GAB2 CEP350 LPIN1 TMPO

4.96e-0419011967305_DN
DrugMianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; PC3; HT_HG-U133A

MAP1A ATXN7L1 SORBS1 XRCC4 MLLT1 UTY

4.96e-0419011965786_UP
Drugradicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

EPN2 C2CD2L MICAL2 TLE3 SIPA1L1 BRPF1

5.10e-0419111961057_DN
DrugHalcinonide [3093-35-4]; Down 200; 8.8uM; PC3; HT_HG-U133A

MAP1A PTPN13 SYNJ2 TLE4 FGD6 BRWD1

5.10e-0419111967379_DN
Drugpioglitazone HCl; Up 200; 10uM; PC3; HT_HG-U133A

PODXL ZNF280B SORBS1 PRDM2 C2CD2L LPIN1

5.10e-0419111965977_UP
DrugSalbutamol [18559-94-9]; Down 200; 16.8uM; PC3; HT_HG-U133A

PHF20 DAB2 XRCC4 ATXN1 WWC1 BRWD1

5.10e-0419111967376_DN
DrugPronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A

CDC42BPA MAP4 PRDM2 ARHGAP1 TMPO KMT2A

5.24e-0419211964104_DN
DrugRemoxipride Hydrochloride [73220-03-8]; Down 200; 9.8uM; HL60; HT_HG-U133A

MAP4 PRDM2 C2CD2L TLE3 KMT2A ZFHX3

5.39e-0419311963124_DN
DrugHaloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A

MAP1A MAP4 CEP350 LPIN1 RGL1 TLE3

5.39e-0419311965273_UP
DrugEthoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A

ANK3 MAP1B MAP4 PRDM2 TMPO BRWD1

5.39e-0419311964321_DN
DrugTalampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A

CDC42BPA C2CD2L IVNS1ABP TLE3 SSX2IP MKI67

5.39e-0419311967014_DN
DrugPrednicarbate [73771-04-7]; Down 200; 8.2uM; PC3; HT_HG-U133A

ATXN7L1 MCC IVNS1ABP VCAN KMT2A WWC1

5.39e-0419311965119_DN
DrugGallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A

CDC42BPA MAP4 XRCC4 TLE3 TLE4 SIPA1L1

5.39e-0419311966215_DN
Drugdansylamide

RBM15 BRIP1 PODXL XK DNAJB2

5.48e-041271195CID000065077
DrugOxantel pamoate [68813-55-8]; Down 200; 6.6uM; MCF7; HT_HG-U133A

ANK3 MAP4 XRCC4 SIPA1L1 SSX2IP AFF4

5.54e-0419411962632_DN
DrugViomycin sulfate [37883-00-4]; Down 200; 5.2uM; MCF7; HT_HG-U133A

CDC42BPA PODXL EPN2 IVNS1ABP SSX2IP DNAJB2

5.54e-0419411967036_DN
Drug5213008; Up 200; 18uM; MCF7; HT_HG-U133A_EA

ANK3 MAP4 EPN2 LPIN1 ARHGAP1 PTPN13

5.54e-041941196898_UP
DrugAcetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; HL60; HG-U133A

MAP1A MAP4 SH3GL1 MCC GAB2 TMPO

5.54e-0419411961377_DN
DrugSulfamethizole [144-82-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A

KIF1A C2CD2L TLE4 TRMT1L DNAJB2 FGD6

5.54e-0419411966272_DN
DrugTrimipramine maleate salt [521-78-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A

PHF20 ARHGAP1 SYNJ2 MICAL2 SIPA1L1 TMPO

5.54e-0419411964163_DN
Drugpioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A

CDC42BPA PHF20 MAP1A XK ARHGAP1 SSX2IP

5.54e-0419411967523_UP
DrugIdoxuridine [54-42-2]; Up 200; 11.2uM; PC3; HT_HG-U133A

FLT1 ATXN7L1 PPP1R14D PRDM2 LPIN1 TLE4

5.54e-0419411964200_UP
DrugIndapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A

RALGDS SH3GL1 ARHGAP1 VCAN ZFHX3 AFF4

5.54e-0419411964335_DN
DrugTetrandrine [518-34-3]; Down 200; 6.4uM; HL60; HT_HG-U133A

KIF1A MAP4 XRCC4 PRDM2 SIPA1L1 WWC1

5.54e-0419411962520_DN
DrugNitrofurantoin [67-20-9]; Down 200; 16.8uM; PC3; HT_HG-U133A

PHF20 MAP4 ATXN7L1 MCC ZFHX3 UTY

5.54e-0419411963674_DN
Diseaseneuroimaging measurement

CDC42BPA ANK3 MAP1B PODXL MARK3 ZDHHC5 XRCC4 DENND4C PLEKHG1 TLE4 VCAN NAV2 FGD6 WWC1 FOXL1

1.45e-05106911315EFO_0004346
Diseasecortical surface area measurement

ZNF536 ANK3 PODXL PLEKHG1 ARHGAP1 ARHGAP31 TLE4 VCAN NAV2 NAV1 ZFHX3 POLD3 LINC02694 FGD6 WWC1 FOXL1

5.44e-05134511316EFO_0010736
DiseaseFanconi anemia (implicated_via_orthology)

BRIP1 USP1

4.01e-0481132DOID:13636 (implicated_via_orthology)
Diseasemyocardial infarction

DAB2IP FLT1 BRIP1 HECTD4 PLEKHG1 FGD6 FOXL1

4.10e-043501137EFO_0000612
Diseasenasopharynx carcinoma (is_marker_for)

DAB2IP FLT1 KMT2C

6.04e-04431133DOID:9261 (is_marker_for)
DiseaseProstatic Neoplasms

DAB2IP PODXL USP28 SLC4A2 IVNS1ABP KMT2C BRPF1 KMT2A ZFHX3

6.19e-046161139C0033578
DiseaseMalignant neoplasm of prostate

DAB2IP PODXL USP28 SLC4A2 IVNS1ABP KMT2C BRPF1 KMT2A ZFHX3

6.19e-046161139C0376358
Diseaseprostate carcinoma

DAB2IP RBM15 USP28 BCLAF1 ZNF280B CEP350 YEATS2 BBX BAIAP2L1 WDR11 ZFHX3

6.33e-0489111311EFO_0001663
Diseasehigh grade glioma (implicated_via_orthology)

RAF1 SH3GL1 MKI67

6.46e-04441133DOID:3070 (implicated_via_orthology)
Diseaseaspartate aminotransferase measurement

BRIP1 MARK3 HECTD4 DAB2 GAB2 LPIN1 RGL1 AP1B1 WDR11 ATXN1 TLE4

7.13e-0490411311EFO_0004736
Diseasenucleus accumbens volume change measurement

MUC16 WWC1

7.82e-04111132EFO_0021493
DiseaseMalignant neoplasm of breast

RAF1 FLT1 BRIP1 SORBS1 RGL1 ZNF532 SYNJ2 TLE3 SIPA1L1 MKI67 BOD1L1 GALNT5

8.59e-04107411312C0006142
Diseaselung adenocarcinoma (is_implicated_in)

KMT2C PTPN13 ZFHX3

8.86e-04491133DOID:3910 (is_implicated_in)
Diseasecolorectal cancer (is_implicated_in)

BRIP1 MCC PTPN13 MKI67

1.23e-031211134DOID:9256 (is_implicated_in)
DiseaseAntithrombotic agent use measurement

FLT1 HECTD4 ZFHX3

1.24e-03551133EFO_0009925
DiseaseColorectal Carcinoma

RALGDS MAP1B TCOF1 ZSCAN5A MCC LPIN1 KMT2C MKI67 POLD3

1.54e-037021139C0009402
DiseaseChromosome Aberrations

XRCC4 KMT2A

1.68e-03161132C0008625
DiseaseAutosome Abnormalities

XRCC4 KMT2A

1.68e-03161132C0004403
DiseaseIntellectual Disability

RALGDS MAP1B MCC SPECC1L KMT2C AP1B1 SCN8A

1.70e-034471137C3714756
Diseaseword reading

ATXN1 ZFHX3 USP1

2.01e-03651133EFO_0005300
Diseasesmoking behavior

CDC42BPA BBX NAV2 ZFHX3 HDGFL2 BRWD1

2.04e-033411136EFO_0004318
DiseaseIdiopathic hypogonadotropic hypogonadism

WDR11 TAC3

2.14e-03181132C0342384
Diseasehemorrhoid

BRIP1 AP1B1 PHLDB2 FOXL1

2.50e-031471134EFO_0009552
Diseasewaist-hip ratio

TCEA3 ANK3 ATXN7L1 HECTD4 DAB2 MCC YEATS2 HAUS8 BBX WDR11 POLD3 PHLDB2

2.61e-03122611312EFO_0004343
Diseaseserum gamma-glutamyl transferase measurement

BRIP1 CDC42BPA MAP1A HECTD4 MCC SPECC1L DCAF5 SYNJ2 NAV2 KMT2A

2.72e-0391411310EFO_0004532
DiseaseHIV-1 infection, Susceptibility to viral and mycobacterial infections

PODXL NAV2

2.91e-03211132EFO_0000180, Orphanet_391311
Diseasecytotoxicity measurement, response to metformin

KIF1A POLD3

2.91e-03211132EFO_0006952, GO_1901558
Diseasecalcium measurement

TCEA3 MAP1A ATXN7L1 GAB2 BBX TLE3 TLE4 ZFHX3

2.92e-036281138EFO_0004838
DiseaseS-6-hydroxywarfarin measurement

GALR1 KATNAL1 DENND4C NAV2 KMT2A ZFHX3

2.98e-033681136EFO_0803326
DiseasePR interval

MARK3 USP28 MICAL2 TLE3 SIPA1L1 NAV2 PHLDB2

3.01e-034951137EFO_0004462
DiseaseParoxysmal atrial fibrillation

ATXN1 NAV2 ZFHX3 PHLDB2

3.10e-031561134C0235480
Diseasefamilial atrial fibrillation

ATXN1 NAV2 ZFHX3 PHLDB2

3.10e-031561134C3468561
DiseasePersistent atrial fibrillation

ATXN1 NAV2 ZFHX3 PHLDB2

3.10e-031561134C2585653
Diseaseatrial fibrillation

RBM15 ATXN1 TLE3 NAV2 ZFHX3 PHLDB2

3.10e-033711136EFO_0000275
Diseasemucocutaneous lymph node syndrome

CENPU SPECC1L ZFHX3

3.14e-03761133EFO_0004246
Diseasecolorectal cancer (is_marker_for)

DAB2IP BRIP1 ZFHX3 AFF4

3.17e-031571134DOID:9256 (is_marker_for)
DiseaseAtrial Fibrillation

ATXN1 NAV2 ZFHX3 PHLDB2

3.39e-031601134C0004238

Protein segments in the cluster

PeptideGeneStartEntry
DSEPSLPRSKSKISK

ZNF280B

526

Q86YH2
SADRKAERTSPSSPA

SLC4A2

161

P04920
RIPSTKSDSETPYKD

COX18

306

Q8N8Q8
EKSSDTTKESRPPDF

BBX

541

Q8WY36
TSKPLESTEPSASSK

VCAN

811

P13611
SKLTKSLPASPSTSD

SSX2IP

531

Q9Y2D8
KSAFKSTSTALPPRE

ERGIC2

146

Q96RQ1
SSTPPGKEAKRSSDT

CENPU

96

Q71F23
PISTSKPLTALSDKR

SPECC1L

891

Q69YQ0
KSLPPRTASSESAES

AP1B1

591

Q10567
ATSRSSEEKAPTLPS

ATXN1

21

P54253
SSSKSSIETKPDASP

GRAMD1B

261

Q3KR37
SSKVKDLSTRSDESP

ATXN7L1

626

Q9ULK2
PKETSSATPGRDSKT

AFF4

521

Q9UHB7
RASDDGKLTDPSKTS

RAF1

41

P04049
SPLKKEDRSDGSAPS

RBM15

741

Q96T37
ALESPAKSPASSSSK

RAD18

96

Q9NS91
TPDEPQKKLSESSSS

RGL1

576

Q9NZL6
LDSTRSLPKASKSEE

RIMBP3B

296

A6NNM3
LDSTRSLPKASKSEE

RIMBP3C

296

A6NJZ7
QPPSKATSDKTDSAL

ANKRD36C

686

Q5JPF3
SSSSKGDSPELKPRA

DAB2IP

971

Q5VWQ8
STPSSFDSLKSPDQK

DAB2

306

P98082
SRPDPTSKKAEQTST

MUC16

3801

Q8WXI7
PTTTIESPKSTKSAD

PODXL

116

O00592
KKSYPDDKPLSSESS

FAM133A

181

Q8N9E0
KRDDDAESTKAPSTP

KMT2C

3611

Q8NEZ4
TSAEKELSSPISPKS

MAP1A

2011

P78559
VSSEKVSPSKSPSLS

MAP1B

1246

P46821
TSTKSPSEDPLTRKS

MAGEB2

101

O15479
TAAEKEKLPSSSSPA

MAGEB17

31

A8MXT2
AKSVPADLSRPKSTS

MAP4

851

P27816
SPLSSKRKALEESES

TMPO

351

P42166
SPTSTPKLSKSLSFE

IVNS1ABP

326

Q9Y6Y0
DSDSSTLSKKPPFVR

WWC1

946

Q8IX03
TVASSKPSSARKTPE

EPN2

496

O95208
KVDDLSSSPTSSPER

DCAF5

621

Q96JK2
PLASAASKISSRDSK

PHRF1

641

Q9P1Y6
APSETPSSSSVVKKR

LPIN1

141

Q14693
RPSTPKSDSELVSKS

LPIN1

246

Q14693
KSSPELEDTATSSKR

MKI67

2826

P46013
ASEPDTTLTKTSPKN

HECTD4

1496

Q9Y4D8
SFSAPRKKSPDLSEA

HAUS8

131

Q9BT25
SSSSDSDVSVKKPPR

HDGFL2

261

Q7Z4V5
SENSASSPPRFKTEK

BRIP1

1026

Q9BX63
ERASKKLPSQPTTDT

BOD1L1

231

Q8NFC6
KLPSQPTTDTSTDKE

BOD1L1

236

Q8NFC6
TKESKSRIDTPPSTN

GALR1

331

P47211
KLSKTRSESSSSDRP

MCC

331

P23508
ARTTSTFKAPASKPE

BAIAP2L1

456

Q9UHR4
KEPDAPSKSKSSSSS

CBX2

96

Q14781
KLDSPSRSPSKVEVT

C2CD2L

461

O14523
EATKRSPSPEEKASR

DNAJB2

306

P25686
FEETRPRTKSDPTSK

FRMPD3

586

Q5JV73
EPRKSHSPSSDTSKL

GALNT5

196

Q7Z7M9
ASPSSPSSREEKESK

BCLAF1

756

Q9NYF8
DTDPKALRLTDSSPS

CEP350

246

Q5VT06
PESEKSSPAVSRSKT

DENND4C

1291

Q5VZ89
DEDKPPSKSSSSEKT

ANK3

3476

Q12955
PSKSSSSEKTPDKTD

ANK3

3481

Q12955
KTSRSALPDAAPVTK

ANKS6

506

Q68DC2
PSKRKSSSVTSSGED

BRWD1

2041

Q9NSI6
EPPSESASNTLRTKK

RALGDS

646

Q12967
ADIPERKKSSTVPSS

MARK3

481

P27448
PASRSSPKSSDKSKS

FOXL1

246

Q12952
SDPSVFSPLNKSETK

KMT2A

191

Q03164
PESKQATTPASRKSS

KMT2A

1281

Q03164
PRTSSSSSFSDKKPA

MLLT1

316

Q03111
PVSSVKTEPKSSDDR

GPRIN1

131

Q7Z2K8
VPLSLEKTKPSSSSR

GPRIN1

711

Q7Z2K8
KTTPSPRHKKSDSSG

KCTD3

796

Q9Y597
ADSKKLPSPARATET

KIF1A

1541

Q12756
SPSTVDSASPARKEK

MICAL2

916

O94851
STNSEAKKRRTASPP

PRDM2

631

Q13029
PSSKRSAVSAPKSTK

PTPN13

1971

Q12923
LESPESSKSTENSPK

PCARE

846

A6NGG8
LKPRSTPKEDDSSAS

EIF4B

336

P23588
DSESKSHPDSSKIPR

PPP1R14D

36

Q9NXH3
ARPKETDHKSLSSSP

PHF20

146

Q9BVI0
RTVKDSTPSSLDSDP

NAV1

1831

Q8NEY1
PHRKPSTSSVTSDEK

GAB2

626

Q9UQC2
PISKSEKPSTSRDKD

KATNAL1

141

Q9BW62
ESKPSKNRSLVPETS

UTY

666

O14607
SPSLASAPEEAKSKR

TRMT1L

66

Q7Z2T5
KKLDSLLTSSETPPS

TEX14

1266

Q8IWB6
SKSSDPLDSGTRSPK

SYNJ2

1431

O15056
SSVSTKESPARKAAP

TCOF1

226

Q13428
SQASKATPKLDSSPS

TCOF1

1216

Q13428
LDSTRSLPKASKSEE

RIMBP3

296

Q9UFD9
ESRKTVLSKPTDSSP

SMG1

1166

Q96Q15
SGDESKKPLPSSSRT

NAV2

1121

Q8IVL1
LVDKSGKRTTSPSSD

PHF12

121

Q96QT6
FPKSDDSKSSSPELV

ARHGAP1

41

Q07960
STRDLRASPKPTSKS

SIPA1L1

1521

O43166
RASPKPTSKSTIEED

SIPA1L1

1526

O43166
VPRAPAESSSSSKKF

POLD3

141

Q15054
SDTLPRKKTTSSISP

PHLDB2

896

Q86SQ0
PASPRKTKSLSLEST

CDC42BPA

1711

Q5VT25
RSPRPSSSSDSDSDK

BRPF1

946

P55201
VKTPSSFPSSLSKER

CNK3/IPCEF1

666

G9CGD6
KFDSKRSPEVASSPS

LINC02694

111

Q8NAA6
DSRNSSTPTEKPKLL

SPG11

91

Q96JI7
SEKNDTSLPSVAPSK

ZNF532

246

Q9HCE3
PKIAASSSFRSSDKP

SH3GL1

281

Q99961
PSKEKSDNPSPSSSR

SRRM5

226

B3KS81
KKDAPISPASIASSS

TLE4

286

Q04727
PEPNTKTRESTSSEK

STX18

171

Q9P2W9
FSEDTKSPLSVPRSK

SORBS1

466

Q9BX66
KENSRPDSSLPETSK

XRCC4

296

Q13426
NSEPSTALTKPRAKS

FGD6

591

Q6ZV73
SPKRSKPDASSISQE

ZSCAN5A

296

Q9BUG6
KSTSLSKASPESQEP

NUP188

1721

Q5SRE5
HREKKESTPSTASLP

SCN8A

1931

Q9UQD0
VDSKSSASSSPKRPS

TCEA3

131

O75764
PAKDDSPSSLESSKE

ARHGAP31

1246

Q2M1Z3
EDSLPKSKPLTSSRS

USP28

506

Q96RU2
ARSLKKDAPTSPASV

TLE3

276

Q04726
SDTTKPKSSLPAVSD

WASF2

421

Q9Y6W5
PSDALKGTDLPSKST

ZNF536

881

O15090
PRTSSSSDDSKRSPL

ZDHHC5

581

Q9C0B5
SSDDSKRSPLGKTPL

ZDHHC5

586

Q9C0B5
STPSKSARDSVRPKS

PLEKHG1

681

Q9ULL1
SPSSKGTSEPEKSLR

USP31

1026

Q70CQ4
STTAPKEAAPRDKLS

WDR11

946

Q9BZH6
TSKSKESGLSDVSRP

FLT1

1276

P17948
QASTDPKESTSPEKR

TAC3

66

Q9UHF0
SRDRDETPSSSKTSP

XK

416

P51811
RSKRKATSDTLESPP

USP1

301

O94782
AIKKFLESPSRSSSP

YEATS2

111

Q9ULM3
SSESPLSSKRPKTAE

ZFHX3

1201

Q15911